Dementia in Alzheimer disease

F5_ALZHDEMENT

Alzheimer's disease: A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F00* Hospital discharge: ICD-8 — 29010 Cause of death: ICD-10 — F00* Cause of death: ICD-8 — 29010 2 out of 7 registries used, show all original rules.	11192
4. Check minimum number of events None	11192
5. Include endpoints None	11192
6. Filter based on genotype QC (FinnGen only)	9892

Control definitions (FinnGen only)

Control exclude: F5_ORGANIC

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF3

NAME	F5_ALZHDEMENT
CONTROL_EXCLUDE	F5_ORGANIC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F00
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	29010
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F00
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	29010
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Dementia in Alzheimer disease based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	128670	81960	45831
Only index persons	110175	71387	38788
Unadjusted period prevalence (%)
Whole population	1.96	2.35	1.28
Only index persons	2.22	2.62	1.48
Median age at first event (years)
Whole population	82.30	83.00	81.09
Only index persons	82.63	83.30	81.39

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9892	4736	5156
Unadjusted period prevalence (%)	2.04	1.68	2.36
Median age at first event (years)	80.97	81.00	80.94

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9567: Matched controls
79987

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.3

314.8

4270

20921

A28

ICPC

Limited function/disability NOS

2.4

309.1

3308

14623

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.5

307.7

1959

5482

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.9

307.7

2757

9918

F0019, G301,

ICD-10 Finland

+∞

307.7

788

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

621.5

307.7

561

N06DA04

ATC

galantamine; oral

248.7

307.7

1398

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

+∞

307.7

3678

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

688.0

307.7

827

WYA20

NOMESCO Finland

Home visit

8.4

307.7

551

578

N05AX08

ATC

risperidone; systemic

21.1

307.7

3346

1989

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

6.9

307.7

2585

4058

P70

ICPC

Dementia

43.9

307.7

1399

311

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

1008.1

307.7

1347

R41.0

ICD-10 Finland

Disorientation, unspecified

5.8

307.7

804

1239

N06DA03

ATC

rivastigmine; oral, transdermal

261.6

307.7

2903

133

SPAT1234

SPAT

Support of social functional capacity

5.1

307.7

1439

2680

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

3490.3

307.7

786

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

269.1

307.7

2899

129

SPAT1245

SPAT

Provision of support and information to patient’s family members

5.6

307.7

1298

2196

SPAT1216

SPAT

Assessment of functional ability

3.0

307.7

2954

10225

N05AH04

ATC

quetiapine; oral

6.3

307.7

2439

4132

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.8

307.7

1651

4170

SPAT1254

SPAT

Administration of medicine

2.7

307.7

2439

8863

N06DA02

ATC

donepezil; oral

278.8

307.7

4414

245

N05BA04

ATC

oxazepam; oral

2.9

307.7

3405

12824

F009, G309,

ICD-10 Finland

+∞

307.7

468

G30.8

ICD-10 Finland

Other Alzheimer disease

127.1

307.7

2029

169

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

122.7

307.7

2634

247

R53

ICD-10 Finland

Malaise and fatigue

2.5

307.7

3231

13719

F03

ICD-10 Finland

Unspecified dementia

40.3

307.7

2000

521

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

793.8

307.7

4408

G30.1

ICD-10 Finland

Alzheimer disease with late onset

139.1

307.7

4554

519

G30.0

ICD-10 Finland

Alzheimer disease with early onset

203.0

307.7

635

P20

ICPC

Memory disturbance

10.3

307.7

4963

7593

F06.7

ICD-10 Finland

Mild cognitive disorder

15.4

307.7

942

562

N06DX01

ATC

memantine; oral

636.1

307.7

6320

244

F05.1

ICD-10 Finland

Delirium superimposed on dementia

580.4

307.7

400

SPAT1053

SPAT

Memory test

5.2

307.7

4023

9724

F05.9

ICD-10 Finland

Delirium, unspecified

48.0

307.7

433

G30

ICD-10 Finland

Alzheimer disease

159.5

307.7

756

F01.9

ICD-10 Finland

Vascular dementia, unspecified

20.5

291.4

251

105

N03AG01

ATC

valproic acid; systemic, rectal

5.0

290.8

694

1225

N05AH03

ATC

olanzapine; systemic

5.5

268.8

571

905

F00

ICD-10 Finland

Dementia in Alzheimer disease

50.7

249.8

167

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.6

248.7

1778

6436

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

243.1

3209

15171

N06AX11

ATC

mirtazapine; oral

2.1

242.8

3370

16245

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.3

240.9

2474

10552

F0009, G300,

ICD-10 Finland

+∞

240.2

246

SPAT1304

SPAT

Counselling and guidance related to ageing

2.6

225.5

1584

5662

N05AD01

ATC

haloperidol; systemic

4.3

212.9

616

1270

AA1AD

NOMESCO Finland

CT of head and brain

2.0

209.2

3729

19453

SPAT1101

SPAT

Orthostatic test

3.3

209.0

914

2509

N02AA05

ATC

oxycodone; systemic

2.1

205.7

2781

13110

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

617.7

205.6

217

Z75.5

ICD-10 Finland

Holiday relief care

7.6

197.2

306

346

F00.14

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type

874.9

195.7

205

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.3

194.3

849

2326

F0014, G301,

ICD-10 Finland

844.3

188.9

198

N06AB10

ATC

escitalopram; oral

2.5

187.0

1371

4971

N06AX26

ATC

vortioxetine; oral

4.0

184.3

570

1234

SPAT1301

SPAT

No procedures

1.9

181.8

3524

18691

F0029, G308,

ICD-10 Finland

+∞

181.4

186

U04

ICPC

Incontinence urine

2.8

178.1

1026

3289

N02BE01

ATC

paracetamol; systemic, rectal

2.3

175.0

8164

57426

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.2

169.0

764

2132

SPAT1229

SPAT

Assessment of need for aid

2.5

167.1

1250

4561

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

16.1

166.5

159

R41.3

ICD-10 Finland

Other amnesia

4.1

166.0

494

1038

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

6.1

161.4

304

426

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

160.0

3841

21572

SPAT1252

SPAT

Overall medication plan or its review

2.6

159.7

1058

3636

TAB00

NOMESCO Finland

Lumbar puncture

4.7

159.0

405

751

SPAT1360

SPAT

Extensive global examination

2.7

157.4

979

3258

L28

ICPC

Limited function/disability (L)

1.9

156.4

2698

13629

SPAT1172

SPAT

Guidance concerning hydration

3.7

155.5

551

1313

SPAT1246

SPAT

Screening of depression or other psychiatric problem

5.8

155.1

311

464

S72.0

ICD-10 Finland

Fracture of neck of femur

2.8

154.5

904

2914

AXX01, ,

SPAT

3.3

154.4

656

1760

N05BA06

ATC

lorazepam; systemic, sublingual

3.0

150.1

752

2225

F001, G301,

ICD-10 Finland

657.6

147.0

155

A06AD11

ATC

lactulose; oral

1.9

144.1

2376

11773

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

3.2

141.0

619

1693

F00.19

ICD-10 Finland

Dementia in Alzheimer's disease with late onset without information about additional symptoms

627.4

140.2

148

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

623.1

139.3

147

I95.1

ICD-10 Finland

Orthostatic hypotension

2.7

132.8

775

2488

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

132.2

1918

9066

AXX01

NOMESCO Finland

Memory assessment

11.8

130.2

147

106

A04

ICPC

Weakness/tiredness general

2.0

129.6

1854

8715

F05.8

ICD-10 Finland

Other delirium

27.9

128.3

SPAT1263

SPAT

Sampling

1.7

121.6

3880

23097

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.2

120.3

1144

4600

S06.0

ICD-10 Finland

Concussion

2.2

119.7

1106

4394

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

117.5

2021

10059

S01.0

ICD-10 Finland

Open wound of scalp

2.3

115.6

1013

3933

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.2

115.2

1187

4925

R1250

NOMESCO Finland

Evaluation of functional capability

4.5

111.5

292

553

N06AB04

ATC

citalopram; systemic

1.9

111.2

1862

9170

OAB76

NOMESCO Finland

General guidance on nutrition and food

32.5

109.7

F00, F03,

ICD-10 Finland

+∞

109.0

112

OAB41

NOMESCO Finland

Guidance and counselling related to ageing

15.3

107.5

105

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

107.3

2968

16876

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

106.8

1727

8399

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

2.1

102.9

1143

4870

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

2.2

100.2

945

3774

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

3.0

99.6

489

1424

Z02.4

ICD-10 Finland

Examination for driving licence

0.5

99.3

1525

20688

SPAT1251

SPAT

Organisation of medication

2.8

98.8

559

1759

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

97.3

3033

17685

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

49.7

96.7

N06AB06

ATC

sertraline; oral

2.4

96.6

723

2610

F0011, G301,

ICD-10 Finland

+∞

96.4

F00.11

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism

+∞

93.4

130

Kela drug reimbursment

Malignant tumour

0.3

89.8

218

6391

SPAT1167

SPAT

Insertion of urinary catheter

2.6

89.4

575

1930

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

20.3

89.3

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

88.2

1890

9940

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

12.0

88.0

E86

ICD-10 Finland

Volume depletion

2.9

87.2

439

1295

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

4.9

86.0

203

352

R55

ICD-10 Finland

Syncope and collapse

1.8

84.5

1453

7153

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

83.3

716

2743

F00.24

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type

189.9

81.3

Z29

ICPC

Social problem NOS

3.8

81.0

264

591

W19

ICD-10 Finland

Unspecified fall

1.9

77.9

1076

4928

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

6.0

76.9

147

209

J01CA08

ATC

pivmecillinam; oral

1.5

76.9

3282

20326

SPAT1139

SPAT

Nutrition survey

2.7

76.7

433

1359

OAB48

NOMESCO Finland

Lifestyle advice and guidance

14.8

74.7

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.4

74.2

560

9743

LAITO, ,

NOMESCO Finland

21.7

73.8

N30.0

ICD-10 Finland

Acute cystitis

1.7

73.8

1672

8878

N05AD03

ATC

melperone; systemic

4.1

71.7

212

442

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.2

71.2

668

2649

SPAT1262

SPAT

Handing over of treatment supplies

1.7

70.2

1775

9687

F0024, G308,

ICD-10 Finland

+∞

70.0

S70.0

ICD-10 Finland

Contusion of hip

2.4

70.0

532

1928

F01.2

ICD-10 Finland

Subcortical vascular dementia

13.8

70.0

F009, F03,

ICD-10 Finland

+∞

69.1

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.4

68.9

499

1769

F22.0

ICD-10 Finland

Delusional disorder

4.8

68.6

165

291

R4110

NOMESCO Finland

Physiotherapy

0.6

68.0

1128

15305

F00.12

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations

+∞

66.1

N07AA05, ,

ATC

+∞

65.2

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.1

65.0

676

2789

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

64.7

721

3053

H02AB02

ATC

dexamethasone; systemic

0.3

64.4

239

5661

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

64.4

740

3170

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.9

63.7

314

915

XA800

NOMESCO Finland

Neuropsychological investigation

3.5

62.5

232

568

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.8

62.4

335

1023

SPAT1279

SPAT

Preparation of immediate hospitalisation

3.6

62.1

219

518

R42

ICD-10 Finland

Dizziness and giddiness

1.5

60.2

2506

15266

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

59.4

3184

20384

SPAT1307

SPAT

Psychosocial counselling and guidance

3.2

59.3

246

647

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

2.2

59.1

532

2072

F00.09

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking

+∞

57.4

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

57.3

2581

15947

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

72.7

57.2

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.4

57.0

424

1520

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.5

56.6

206

498

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.2

55.2

477

1826

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.5

54.3

142

269

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.4

53.9

407

1469

WX402

NOMESCO Finland

General anaesthesia

0.5

53.2

515

8295

F0012, G301,

ICD-10 Finland

469.7

52.7

F00.21

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism

469.7

52.7

A29

ICPC

General symptom/complaint other

1.6

52.5

1342

7292

Z2221

NOMESCO Finland

Medical doctor

0.6

52.1

1117

14344

A03FA01

ATC

metoclopramide; systemic, rectal

0.6

51.8

936

12552

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.7

51.4

1125

5872

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

2.6

51.4

306

986

SPAT1260

SPAT

Consultation of another employee

1.6

50.9

1577

8963

SPAT1125

SPAT

Stoma care and guidance

2.7

50.7

282

877

F01.3

ICD-10 Finland

Mixed cortical and subcortical vascular dementia

25.8

50.5

F002, G308,

ICD-10 Finland

232.2

50.4

P29

ICPC

Psychological sympt/compl other

2.8

49.4

265

809

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.6

49.2

315

1053

F00.22

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations

435.8

48.9

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

48.7

3575

23985

F00.13

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression

+∞

48.6

C10AA01

ATC

simvastatin; oral

1.4

46.8

4929

34978

J01DB01

ATC

cefalexin; oral

1.4

45.0

6528

48599

F00.01

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism

+∞

44.7

F21, ,

ICPC

3.9

44.6

138

298

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

44.4

761

3703

F00.2

ICD-10 Finland

Dementia in Alzheimer disease, atypical or mixed type

393.4

44.1

A10AB05

ATC

insulin aspart; parenteral

1.8

43.6

724

3490

Z03

ICPC

Housing/neighbourhood problem

5.2

43.2

152

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

42.9

2148

13414

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

50.4

42.6

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

42.4

3903

26968

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

100.8

41.4

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.6

41.0

883

11418

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

40.9

1329

7602

F0013, G301,

ICD-10 Finland

+∞

40.8

F0021, G308,

ICD-10 Finland

+∞

40.8

SPAT1310

SPAT

Counselling related to known health issue

1.4

40.7

2520

16311

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

40.6

1375

7936

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

2.9

40.3

204

604

F00.29

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms

359.6

40.2

Z28

ICPC

Limited function/disability (Z)

5.1

39.9

144

Z13.3

ICD-10 Finland

Special screening examination for mental and behavioural disorders

17.8

39.5

Z51.5

ICD-10 Finland

Palliative care

1.6

39.5

1184

6650

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.7

39.3

830

4277

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

0.6

39.3

1086

13288

J01EA01

ATC

trimethoprim; systemic

1.4

38.9

2469

16026

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

38.8

1502

8906

E0000UV, ,

ATC

1.3

38.0

3213

21804

F00.23

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression

+∞

37.9

F01.10

ICD-10 Finland

Multi-infarct dementia without additional symptoms

17.3

37.9

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.7

37.8

860

4516

G31.0

ICD-10 Finland

Circumscribed brain atrophy

6.3

37.8

R44.3

ICD-10 Finland

Hallucinations, unspecified

5.7

37.5

109

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

37.5

1045

5768

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.4

37.4

268

945

F0022, G308,

ICD-10 Finland

334.2

37.3

ZXD10

NOMESCO Finland

Scheduled procedure

0.7

37.1

2150

22978

N02AJ06

ATC

codeine and paracetamol; systemic

0.7

36.2

1792

19680

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

35.9

3441

23735

R44.1

ICD-10 Finland

Visual hallucinations

5.0

35.7

136

SPAT1284

SPAT

Extensive health certificate

2.7

35.6

207

660

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1.9

35.6

463

2064

L82

ICD-10 Finland

Seborrhoeic keratosis

0.6

35.0

752

9769

A04AA02

ATC

granisetron; systemic, transdermal

0.3

34.7

2535

Z60.8

ICD-10 Finland

Other problems related to social environment

6.5

34.3

IHZ08

NOMESCO Finland

Provision of support and information for patient’s relatives

16.8

34.2

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.3

33.3

270

1006

P04

ICPC

Feeling/behaving irritable/angry

8.6

33.2

-2, ,

ICPC

3.9

32.8

100

214

F00.04

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type

291.8

32.5

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

32.4

651

3307

F0024, G301,

ICD-10 Finland

+∞

32.1

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.7

32.0

952

11538

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.7

31.9

174

537

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

1.9

31.7

417

1865

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

31.6

325

1332

TPH04

NOMESCO Finland

Cathetrisation of vein

0.7

30.8

1099

12858

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

7.4

30.4

N06AX16

ATC

venlafaxine; oral

1.7

30.0

613

3126

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

2.7

29.5

164

511

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.6

29.3

677

8678

F009, G301,

ICD-10 Finland

+∞

29.2

SPAT1325

SPAT

Vaccination

1.3

29.1

3333

23371

JN4AD

NOMESCO Finland

Body CT examination

0.6

28.8

478

6641

IHZ08, ,

SPAT

5.0

28.4

107

XX9LA

NOMESCO Finland

Complementary kinetic X-ray examination without contrast

3.4

28.4

106

262

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.2

27.9

1825

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.2

27.9

1726

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

0.4

27.8

144

2962

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.9

27.7

139

410

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

2.9

27.7

139

410

G72.8

ICD-10 Finland

Other specified myopathies

2.4

27.6

195

684

F0004, G300,

ICD-10 Finland

+∞

27.2

F0023, G308,

ICD-10 Finland

+∞

27.2

EB4VA, ,

NOMESCO Finland

0.4

27.2

149

2995

W06

ICD-10 Finland

Fall involving bed

3.0

27.1

125

352

WX408

NOMESCO Finland

General anesthesy, balanced

0.7

26.8

1109

12668

SPAT1050

SPAT

Extensive neurological examination

2.4

26.6

193

686

AA1CG, ,

SPAT

4.2

26.5

145

SPAT1138

SPAT

Guidance concerning bowel function

2.5

26.4

178

611

A98

ICPC

Health maint/preventive medicine

1.3

26.3

7105

55108

2900A

ICD-9 Finland

Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated

+∞

26.2

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.9

26.1

324

1422

ICB01, ,

SPAT

5.2

26.0

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.7

26.0

1651

17611

WX404

NOMESCO Finland

Intravenous generell anesthesy

0.6

25.6

667

8346

G04CB01

ATC

finasteride; oral

1.4

25.5

1550

9894

R45.1

ICD-10 Finland

Restlessness and agitation

7.8

25.5

H02AA02

ATC

fludrocortisone; oral

3.1

25.3

110

299

Z3226

NOMESCO Finland

Physiotherapist

0.7

25.3

795

9572

Z2445

NOMESCO Finland

Psychologist

2.8

25.2

127

376

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

39.5

25.1

TQW40, ,

SPAT

0.5

25.1

236

3882

P05

ICPC

Senility, feeling/behaving old

3.5

25.0

221

AA1BG, ,

SPAT

2.9

25.0

120

346

F06.0

ICD-10 Finland

Organic hallucinosis

44.7

24.9

C03DA01

ATC

spironolactone; oral

0.7

24.9

829

9870

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

0.4

24.7

145

2835

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.3

24.7

1867

XF400

NOMESCO Finland

ECG with 12 standard connections

0.7

24.6

970

11201

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

24.5

952

5613

G31.1

ICD-10 Finland

Senile degeneration of brain, not elsewhere classified

9.3

24.4

F01

ICD-10 Finland

Vascular dementia

6.5

24.3

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

4.3

24.2

130

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.4

24.2

1550

9968

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.5

24.0

155

522

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.3

23.9

1898

R74

ICPC

Upper respiratory infection acute

0.7

23.7

661

8162

L75

ICPC

Fracture: femur

2.3

23.6

190

707

N03AX14

ATC

levetiracetam; systemic

2.2

23.6

212

826

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.0

23.5

248

1027

WX002

NOMESCO Finland

Sedation and analgesia

0.7

23.5

947

10901

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

2.1

23.5

226

904

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.1

23.3

221

879

F0019, G309,

ICD-10 Finland

+∞

23.3

N29

ICPC

Neurological sympt/complt other

2.4

23.3

164

575

A04AA01

ATC

ondansetron; systemic, rectal

0.5

23.1

223

3639

SPAT1312

SPAT

General health counselling

1.3

23.1

2268

15486

-, ,

ICD-10 Finland

2.1

23.0

226

911

SPAT1104

SPAT

Monitoring of emergency patient

1.6

23.0

585

3150

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.2

22.9

1421

G04CA02

ATC

tamsulosin; oral

1.3

22.9

2866

20165

JN4BD

NOMESCO Finland

Extensive body CT

0.6

22.9

456

6071

R33

ICD-10 Finland

Retention of urine

1.4

22.9

1027

6220

Y94.1

ICD-10 Finland

Accident in connection with service housing

10.2

22.8

Z11

ICPC

Compliance/being ill problem

3.6

22.8

182

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

75.5

22.8

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

2.5

22.5

147

498

A69

ICPC

General and Unspecified, Other reason for encounter NEC

1.9

22.5

275

1201

C10AX09

ATC

ezetimibe; oral

0.7

22.3

667

8126

R11

ICD-10 Finland

Nausea and vomiting

1.5

22.3

744

4253

S00.0

ICD-10 Finland

Superficial injury of scalp

2.1

22.2

232

958

E000001, ,

ATC

1.4

22.2

1404

9000

EB1VA, ,

NOMESCO Finland

0.6

22.0

375

5191

A10AE04

ATC

insulin glargine; parenteral

1.5

21.9

818

4782

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

21.9

1383

8862

ZX120

NOMESCO Finland

Intravenous

0.6

21.7

344

4852

TPH07

NOMESCO Finland

Cathetrisation of artery

0.6

21.6

529

6723

R54

ICD-10 Finland

Senility

3.0

21.6

274

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.7

21.6

798

9340

Z08

ICPC

Social welfare problem

3.1

21.5

257

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

4.9

21.2

N05AB03

ATC

perphenazine; systemic, rectal

2.1

21.2

195

767

F00.02

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions

192.7

21.0

F09

ICD-10 Finland

Unspecified organic or symptomatic mental disorder

100.6

20.9

L01BC06

ATC

capecitabine; oral

0.3

20.9

1644

SPAT1097

SPAT

Recording of ECG

1.3

20.7

1343

8633

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.7

20.6

421

2147

P28

ICPC

Limited function/disability (P)

4.3

20.5

107

F01.0

ICD-10 Finland

Vascular dementia of acute onset

37.7

20.5

R1210, ,

SPAT

3.9

20.4

133

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.8

20.4

300

1392

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

5.3

20.4

R06.0

ICD-10 Finland

Dyspnoea

0.8

20.2

1855

18947

N02AX02

ATC

tramadol; systemic, rectal

0.8

20.2

2762

26920

SPAT1281

SPAT

Other administrative function

1.5

20.1

580

3213

WYA20, ,

SPAT

3.1

20.1

237

R50.9

ICD-10 Finland

Fever, unspecified

1.4

19.9

1208

7688

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

32.3

19.8

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.0

19.8

261

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.7

19.8

382

1919

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

0.5

19.7

165

2824

T93

ICPC

Lipid disorder

0.5

19.6

189

3086

A27

ICPC

Fear of other disease NOS

1.6

19.6

422

2182

XF606, ,

SPAT

2.9

19.5

268

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

2.6

19.5

118

386

N07AA06, ,

ATC

+∞

19.4

Z51.88

ICD-10 Finland

Other specified medical care

2.1

19.3

190

768

C04AE01

ATC

ergoloid mesylates; systemic

2.7

19.1

106

332

F00.0

ICD-10 Finland

Dementia in Alzheimer disease with early onset

92.2

19.0

SPAT1255

SPAT

Intravenous administration of medicine

1.5

18.9

568

3174

N27

ICPC

Fear of neurological disease other

2.2

18.9

160

609

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.8

18.9

1488

15520

L08

ICPC

Shoulder symptom/complaint

0.7

18.8

956

10621

HA1RA, ,

SPAT

0.1

18.7

941

ZXE00

NOMESCO Finland

One hour or less

0.8

18.6

2218

22007

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

18.6

320

1557

F000, G300,

ICD-10 Finland

+∞

18.5

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

5.2

18.4

N06AX21

ATC

duloxetine; oral

1.5

18.4

635

3654

SPAT1014

SPAT

Treatment of eyes

2.1

18.4

185

755

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

18.3

778

4660

N05AX12

ATC

aripiprazole; systemic

3.1

18.2

211

Z00.0

ICD-10 Finland

General medical examination

1.3

18.2

1484

9846

K08.3

ICD-10 Finland

Retained dental root

1.5

18.2

576

3255

SPAT1313

SPAT

Guidance and counselling related to accident prevention

3.2

18.2

194

NFB10

NOMESCO Finland

Primary partial prosthetic replacement of hip joint not using cement, other or unspecified

3.4

18.2

165

M04AA01

ATC

allopurinol; systemic

0.7

18.1

1027

11225

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

0.7

18.1

621

7382

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.6

18.1

448

5685

SDA03

NOMESCO Finland

Periodontal treatment

0.8

17.6

1320

13875

F0021, G301,

ICD-10 Finland

+∞

17.5

3310A

ICD-9 Finland

Other cerebral degenerations, Alzheimer's disease

+∞

17.5

L15

ICPC

Knee symptom/complaint

0.7

17.5

1106

11905

J96.1

ICD-10 Finland

Chronic respiratory failure

0.4

17.5

1636

F32

ICD-10 Finland

Depressive episode

2.0

17.4

203

874

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

0.1

17.4

859

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

8.1

17.2

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

4.2

17.2

F01.34

ICD-10 Finland

Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type

159.2

17.2

F0020, G301,

ICD-10 Finland

83.8

17.2

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

0.8

17.1

1342

14034

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

3.0

17.0

211

R05

ICPC

Cough

0.7

16.9

1056

11390

Z75.0

ICD-10 Finland

Medical services not available in home

4.5

16.8

R01AD58

ATC

fluticasone, combinations; nasal

0.7

16.6

479

5891

F009, G308,

ICD-10 Finland

+∞

16.5

H04AA01

ATC

glucagon; nasal, parenteral

2.9

16.5

233

R03AK03

ATC

[U] fenoterol and ipratropium bromide

0.6

16.5

408

5183

SPAT1081

SPAT

Cardiorespiratory global assessment

1.5

16.3

541

3086

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.8

16.3

248

1164

L57.0

ICD-10 Finland

Actinic keratosis

0.7

16.2

802

8965

Y94.0

ICD-10 Finland

Accident at home

2.0

16.0

177

748

K03.64

ICD-10 Finland

Dental calculus supragingival

0.7

16.0

897

9840

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.8

16.0

1653

16729

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

16.0

254

1208

N99

ICPC

Neurological disease other

2.6

16.0

323

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.6

15.9

415

2248

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

1.8

15.9

247

1168

WPA10, ,

SPAT

4.1

15.9

S29

ICPC

Skin symptom/complaint other

0.7

15.9

1009

10866

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

15.8

612

3599

WX302

NOMESCO Finland

Thoracal epidural anesthesy

0.5

15.7

133

2265

WF002

NOMESCO Finland

Radical radiotherapy

0.5

15.6

174

2712

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

15.5

834

5196

S18

ICPC

Laceration/cut

0.8

15.5

3006

28512

UJF30

NOMESCO Finland

Ileoscopy through colon

0.6

15.5

327

4303

EB1AA, ,

SPAT

0.4

15.4

1666

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

0.3

15.4

1272

N28

ICPC

Limited function/disability (N)

2.1

15.4

145

578

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

15.4

3765

28105

Z27

ICPC

Fear of a social problem

4.8

15.3

S22.3

ICD-10 Finland

Fracture of rib

1.5

15.3

559

3252

F06.2

ICD-10 Finland

Organic delusional [schizophrenia-like] disorder

75.4

15.3

Z01.7

ICD-10 Finland

Laboratory examination

0.7

15.3

624

7204

G04BD07

ATC

tolterodine; oral

1.5

15.1

527

3039

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

1.9

15.1

180

782

A10BK01

ATC

dapagliflozin; oral

0.6

15.1

264

3633

R03AK07

ATC

formoterol and budesonide; inhalant

0.7

15.0

689

7799

IHA21

NOMESCO Finland

Mini-intervention for hazardous and harmful alcohol use

23.0

15.0

WW500

NOMESCO Finland

Blood transfusion

0.5

15.0

124

2127

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

6.8

15.0

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

0.2

14.9

808

N05CD07

ATC

temazepam; oral

1.3

14.9

1333

8936

A10AE05

ATC

insulin detemir; parenteral

1.6

14.9

393

2136

A97

ICPC

No disease

0.8

14.9

951

10241

Z60.9

ICD-10 Finland

Problem related to social environment, unspecified

4.4

14.9

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

0.2

14.8

959

G91.0

ICD-10 Finland

Communicating hydrocephalus

3.4

14.7

129

ZYY01

NOMESCO Finland

Contact between professionals

6.9

14.7

L17

ICPC

Foot/toe symptom/complaint

0.8

14.7

1627

16358

N05AH02

ATC

clozapine; systemic

4.1

14.7

R02

ICPC

Shortness of breath/dyspnoea

0.7

14.6

743

8281

L12

ICPC

Hand/finger symptom/complaint

0.7

14.6

612

7035

SPAT1285

SPAT

Provision of consultation response

1.6

14.6

397

2172

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

3.8

14.6

102

F0001, G300,

ICD-10 Finland

+∞

14.6

F0009, G309,

ICD-10 Finland

+∞

14.6

SCA02

NOMESCO Finland

Preventive oral health care

1.5

14.5

473

2689

R03AC02

ATC

salbutamol; inhalant

0.8

14.5

3078

29011

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

14.5

2544

18379

GD1AA, ,

SPAT

0.6

14.4

267

3625

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.6

14.4

364

1957

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.1

14.4

143

582

UGC12

NOMESCO Finland

Flexible bronchoscopy

0.7

14.4

435

5305

WZC00

NOMESCO Finland

Treatment plan or consultation

0.8

14.3

1779

17667

D07AA02

ATC

hydrocortisone; topical

1.3

14.2

875

5567

WZC30

NOMESCO Finland

Teaching

0.7

14.2

701

7849

A10BK03

ATC

empagliflozin; oral

0.7

14.1

395

4894

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.2

14.1

114

427

L03AA02

ATC

filgrastim; parenteral

0.3

14.0

1099

B01AB10

ATC

tinzaparin; parenteral

0.7

14.0

401

4945

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

1.9

14.0

168

732

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

1.9

13.9

164

711

K59.0

ICD-10 Finland

Constipation

1.4

13.7

559

3319

M25.5

ICD-10 Finland

Pain in joint

0.8

13.7

1233

12717

R44.0

ICD-10 Finland

Auditory hallucinations

4.0

13.7

S21

ICPC

Skin texture symptom/complaint

0.7

13.6

724

8019

F00.03

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression

+∞

13.6

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

13.6

1299

8774

D19

ICPC

Teeth/gum symptom/complaint

0.8

13.5

934

9962

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.0

13.5

144

602

IGP01

NOMESCO Finland

Psychiatric family contact

5.7

13.4

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

0.5

13.3

128

2089

C10AA07

ATC

rosuvastatin; oral

0.8

13.3

1639

16321

XQ858, ,

SPAT

2.9

13.3

182

TPX10

NOMESCO Finland

Implantation of vascular injection port

0.3

13.3

1079

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

0.7

13.2

577

6591

R4110, ,

SPAT

0.7

13.1

517

6005

R03BB01

ATC

ipratropium bromide; inhalant

0.6

13.1

279

3661

G04BD08

ATC

solifenacin; oral

1.4

13.0

620

3784

XF402

NOMESCO Finland

ECG with work load test

0.7

12.9

514

5966

AA1AD, ,

SPAT

2.8

12.9

199

S28

ICPC

Limited function/disability (S)

2.6

12.8

257

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

0.5

12.8

116

1930

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

0.4

12.8

1222

4289X

ICD-9 Finland

Heart failure, unspecified

0.2

12.8

466

G03CA04

ATC

estriol; systemic, vaginal

1.3

12.8

804

5130

K85

ICPC

Elevated blood pressure

0.8

12.8

1046

10919

J01MA02

ATC

ciprofloxacin; systemic

1.2

12.7

3441

25788

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

0.5

12.6

139

2173

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

0.1

12.6

446

F0001, G301,

ICD-10 Finland

+∞

12.6

F07.9

ICD-10 Finland

Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction

+∞

12.6

W0A10

NOMESCO Finland

Mapping of psychosocial situation

11.2

12.6

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.7

12.6

211

P15

ICPC

Chronic alcohol abuse

2.4

12.6

310

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.5

12.5

455

2645

XQ855, ,

SPAT

2.3

12.5

337

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

0.7

12.5

460

5411

F0022, G301,

ICD-10 Finland

117.2

12.5

N18

ICPC

Paralysis/weakness

1.8

12.5

180

834

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

0.6

12.4

217

2984

EBA30

NOMESCO Finland

Extraction of root of tooth

1.5

12.3

414

2370

250, ,

Kela drug reimbursment

0.4

12.3

1164

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

12.3

619

3815

S06.3

ICD-10 Finland

Focal brain injury

2.1

12.2

109

427

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.5

12.2

415

2384

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.6

12.1

164

2414

F01.24

ICD-10 Finland

Subcortical vascular dementia other additional symptoms of mixed type

21.5

12.1

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

0.7

12.1

473

5507

SPAT1111

SPAT

Planning of analgesia

2.2

12.0

100

381

IGV01

NOMESCO Finland

Psychiatric network contact

4.8

11.9

WX100

NOMESCO Finland

Conjunctival surface anesthesia

0.8

11.9

944

9905

HA1AA

NOMESCO Finland

X-ray mammography

0.6

11.9

219

2976

S32.5

ICD-10 Finland

Fracture of pubis

2.1

11.9

111

442

R32

ICD-10 Finland

Unspecified urinary incontinence

1.6

11.8

254

1315

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

0.4

11.8

1178

A69.2

ICD-10 Finland

Lyme disease

0.5

11.8

146

2203

PJA12

NOMESCO Finland

Sentinel node biopsy

0.6

11.8

219

2969

S52.5

ICD-10 Finland

Fracture of lower end of radius

1.3

11.7

738

4710

M01AC06

ATC

meloxicam; systemic, rectal

1.2

11.7

2439

17839

ZYY02

NOMESCO Finland

Contact between professionals and family members

18.8

11.7

F0002, G300,

ICD-10 Finland

+∞

11.7

F0014, G309,

ICD-10 Finland

+∞

11.7

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.4

11.6

1300

AA3AD

NOMESCO Finland

CT of face

2.5

11.6

245

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.6

11.6

263

1381

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

0.2

11.6

435

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

2.9

11.6

164

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.4

11.5

1153

WF004

NOMESCO Finland

Palliative radiotherapy

0.4

11.5

1127

XX3DW

NOMESCO Finland

Time consuming IT work

0.7

11.5

447

5206

S82

ICPC

Naevus/mole

0.7

11.4

515

5855

R03DA04

ATC

theophylline; systemic, rectal

0.7

11.4

391

4659

I95.9

ICD-10 Finland

Hypotension, unspecified

1.8

11.4

157

718

A04AA55

ATC

palonosetron, combinations; systemic

0.2

11.4

613

ZX120, ,

SPAT

2.1

11.3

111

451

F38

ICPC

Eye, Other laboratory test NEC

0.2

11.3

709

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

0.7

11.3

329

4043

M02AA07

ATC

piroxicam; topical

1.2

11.3

3059

22865

EB1SA, ,

SPAT

0.3

11.2

902

C03CA01

ATC

furosemide; systemic

1.2

11.2

4402

33862

M01AH05

ATC

etoricoxib; oral

0.9

11.1

2896

27008

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

0.5

11.1

136

2056

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

0.2

11.1

714

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

1.8

11.1

154

706

S12

ICPC

Insect bite/sting

0.7

11.1

348

4214

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

1.7

11.1

210

1054

WX892

NOMESCO Finland

Monitored bed care

0.7

11.1

326

3996

K80

ICPC

Cardiac arrhythmia NOS

0.7

11.0

358

4310

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

2.3

11.0

308

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

0.1

11.0

555

J01CA04

ATC

amoxicillin; systemic

1.2

11.0

5897

46394

T03

ICPC

Loss of appetite

3.1

11.0

124

T68

ICD-10 Finland

Hypothermia

3.1

10.9

120

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

0.2

10.9

595

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.6

10.9

256

3287

ZXE20

NOMESCO Finland

More than three and less than five hours

0.8

10.9

694

7495

N02BF01

ATC

gabapentin; oral

0.7

10.9

335

4070

WX722

NOMESCO Finland

PEEP

0.5

10.8

133

2009

Z01.2

ICD-10 Finland

Dental examination

0.8

10.8

1802

17469

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.6

10.8

254

1347

G04BD12

ATC

mirabegron; oral

1.3

10.8

1073

7274

SPAT1240

SPAT

Therapeutic discussion

1.5

10.7

333

1877

H02AB07

ATC

prednisone; oral

0.8

10.7

773

8213

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.6

10.7

200

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

0.6

10.7

141

2088

F01.1

ICD-10 Finland

Multi-infarct dementia

54.3

10.7

L03

ICPC

Low back symptom/complaint

0.8

10.7

1312

13106

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

0.7

10.6

499

5638

L01CA04

ATC

vinorelbine; systemic

0.1

10.6

361

Z74.2

ICD-10 Finland

Need for assistance at home and no other household member able to render care

11.2

10.6

SPAT1394

SPAT

Counselling and guidance related to living conditions

3.9

10.6

M05BA02

ATC

clodronic acid; systemic

0.1

10.6

319

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

0.5

10.6

1401

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

0.4

10.6

1228

F07.8

ICD-10 Finland

Other organic personality and behavioural disorders due to brain disease, damage and dysfunction

100.5

10.6

D06BB10

ATC

imiquimod; topical

0.6

10.6

208

2779

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

2.2

10.6

352

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

1.9

10.5

123

533

W18

ICD-10 Finland

Other fall on same level

2.4

10.5

257

WX110, ,

SPAT

0.4

10.5

1283

T90.5

ICD-10 Finland

Sequelae of intracranial injury

2.7

10.5

178

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

0.6

10.5

179

2474

R1250, ,

SPAT

1.7

10.4

202

1020

A91

ICPC

Abnormal result investigation NOS

0.6

10.4

174

2417

S01.9

ICD-10 Finland

Open wound of head, part unspecified

1.9

10.4

139

631

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

0.3

10.3

724

S42.0

ICD-10 Finland

Fracture of clavicle

1.7

10.3

168

809

H02AB06

ATC

prednisolone; systemic

0.9

10.3

3328

30586

SPAT1127

SPAT

Enema

2.1

10.3

367

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.5

10.3

350

2012

S01

ICD-10 Finland

Open wound of head

2.1

10.3

395

R01AD59

ATC

mometasone, combinations; nasal

0.3

10.3

862

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

1.9

10.2

136

616

F01.8

ICD-10 Finland

Other vascular dementia

20.9

10.1

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.7

10.1

275

3424

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.4

10.1

373

2179

I50.1

ICD-10 Finland

Left ventricular failure

0.7

10.1

376

4412

A11CC03

ATC

alfacalcidol; systemic

0.4

10.1

1191

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.2

10.0

3051

22957

R45.5

ICD-10 Finland

Hostility

16.7

10.0

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

0.4

10.0

1107

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

10.0

1167

8051

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.6

10.0

210

1084

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.2

10.0

105

KMAK, ,

NOMESCO Finland

1.2

10.0

2638

19635

P99

ICPC

Psychological disorders other

2.3

10.0

269

WX111

NOMESCO Finland

Local infiltration anesthesia

0.5

9.9

1513

GD1AD

NOMESCO Finland

Thorax CT examination

0.6

9.8

237

3024

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.0

9.8

402

F06.8

ICD-10 Finland

Other specified mental disorders due to brain damage and dysfunction and to physical disease

50.2

9.8

N07

ICPC

Convulsion/seizure

5.2

9.8

L13

ICPC

Hip symptom/complaint

0.8

9.7

1081

10921

F0010, G308,

ICD-10 Finland

+∞

9.7

F0023, G301,

ICD-10 Finland

+∞

9.7

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

+∞

9.7

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

0.6

9.7

133

1946

N03AX18

ATC

lacosamide; systemic

3.4

9.7

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.2

9.7

299

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

0.3

9.7

723

L76

ICPC

Fracture: other

1.5

9.7

261

1429

TDA90, ,

SPAT

0.7

9.7

300

3641

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

0.3

9.7

812

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

0.4

9.7

971

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.5

9.7

309

1755

Z3231

NOMESCO Finland

Registered nurse

0.8

9.6

1670

16158

L03AA13

ATC

pegfilgrastim; parenteral

0.5

9.6

1375

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

0.4

9.6

884

RD211, ,

NOMESCO Finland

1.5

9.6

269

1486

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

0.6

9.6

216

2797

G04BD10

ATC

darifenacin; oral

2.3

9.6

258

A10BB12

ATC

glimepiride; oral

1.3

9.5

812

5398

AA1ED

NOMESCO Finland

Trauma CT of head and neck

2.6

9.5

168

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

2.8

9.5

149

K02.0

ICD-10 Finland

Caries limited to enamel

0.7

9.5

375

4359

ZYB04, ,

SPAT

3.4

9.5

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.6

9.5

213

1118

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.3

9.5

987

6723

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

0.3

9.5

803

F16

ICPC

Eyelid symptom/complaint

0.6

9.5

129

1889

N05CF01

ATC

zopiclone; oral

1.2

9.4

2984

22496

N06AX12

ATC

bupropion; oral

1.9

9.4

122

548

AA1AA

NOMESCO Finland

Head X-ray examination

2.3

9.4

250

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

0.8

9.4

1199

11942

N03AF02

ATC

oxcarbazepine; oral

1.7

9.3

172

858

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

1.7

9.3

168

834

Z74.1

ICD-10 Finland

Need for assistance with personal care

13.4

9.3

SCF02

NOMESCO Finland

Preventive oral care by dental hygienist

1.8

9.3

139

654

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

4.9

9.2

WX320

NOMESCO Finland

Spinalanesthesy

0.8

9.2

1442

14082

SPAT1131

SPAT

Colonoscopy

1.6

9.2

239

1300

S20.2

ICD-10 Finland

Contusion of thorax

1.4

9.2

338

1975

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

0.7

9.1

300

3600

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.6

9.1

218

1162

S72.2

ICD-10 Finland

Subtrochanteric fracture

2.0

9.1

414

B01AC07

ATC

dipyridamole; systemic

1.3

9.1

693

4543

G04CA01

ATC

alfuzosin; oral

1.2

9.0

1127

7828

F10.24

ICD-10 Finland

Alcohol depence active use

2.7

9.0

144

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

0.4

9.0

978

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.2

9.0

1025

7050

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

0.6

9.0

195

2546

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

0.1

9.0

281

IHA10

NOMESCO Finland

Structured mapping of problematic alcohol use

2.9

9.0

126

S09.9

ICD-10 Finland

Unspecified injury of head

1.9

8.9

117

528

P19

ICPC

Drug abuse

4.4

8.9

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

0.5

8.9

1404

F01.22

ICD-10 Finland

Subcortical vascular dementia with additional symptoms, mainly hallucinations

46.0

8.9

G04CB02

ATC

dutasteride; oral

1.3

8.8

796

5329

ZY010

NOMESCO Finland

Hospital outpatient

1.6

8.8

182

937

Z76.0

ICD-10 Finland

Issue of repeat prescription

0.8

8.7

1036

10404

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

0.3

8.7

605

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.7

8.7

150

736

J01.0

ICD-10 Finland

Acute maxillary sinusitis

0.8

8.7

653

6904

Z75.9

ICD-10 Finland

Unspecified problem related to medical facilities and other health care

3.0

8.6

106

SPAT1243

SPAT

Psychiatric/psychological examination

2.5

8.6

182

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

1.7

8.6

150

739

J01DA06

ATC

[U] cefuroxime

0.8

8.5

599

6391

ZX090

NOMESCO Finland

Other technic of radiotherapy

0.5

8.5

1117

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

8.5

299

1731

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.6

8.5

149

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

0.3

8.5

594

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

1.6

8.5

185

966

90621, ,

NOMESCO Finland

2.8

8.5

121

M02AA10

ATC

ketoprofen; topical

1.2

8.4

1175

8253

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.4

8.4

416

2560

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.4

8.4

400

2446

Z50.1

ICD-10 Finland

Other physical therapy

0.6

8.4

186

2415

NFJ52

NOMESCO Finland

Internal fixation of fracture of upper femur with screws and sideplate

1.9

8.4

427

XG460

NOMESCO Finland

Short time oxymetry

0.4

8.3

899

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

0.6

8.3

196

2512

I49.3

ICD-10 Finland

Ventricular premature depolarization

0.7

8.3

276

3306

XKD00

NOMESCO Finland

Uroflowmetry

1.2

8.3

1601

11585

ZYY79

NOMESCO Finland

Other indirect service without contact with patient

10.3

8.3

ZY000

NOMESCO Finland

Hospital inpatient

2.9

8.3

113

E979A

ICD-9 Finland

DAMAGE OCCURRED BY ANOTHER OR SPECIFIED WAY

3.3

8.3

H01

ICPC

Ear pain/earache

0.7

8.3

313

3663

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

0.3

8.3

663

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

0.6

8.2

105

1564

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

4.1

8.2

K59.09

ICD-10 Finland

Constipation, unspecified

1.3

8.2

610

3987

N80

ICPC

Head injury other

1.7

8.2

137

667

M70.6

ICD-10 Finland

Trochanteric bursitis

0.8

8.2

641

6743

F30.9

ICD-10 Finland

Manic episode, unspecified

5.0

8.1

R4190

NOMESCO Finland

Nutritional therapy

0.4

8.1

877

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

3.8

8.1

B81

ICPC

Anaemia vit B12/folate deficiency

1.4

8.1

361

2184

S01.3

ICD-10 Finland

Open wound of ear

2.0

8.1

368

K86

ICPC

Hypertension uncomplicated

0.8

8.1

848

8629

K03.66

ICD-10 Finland

Tooth plaque

1.4

8.1

430

2678

A10BH05

ATC

linagliptin; oral

1.3

8.0

520

3334

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

0.7

8.0

344

3942

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

1.6

8.0

159

811

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

0.6

8.0

104

1540

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

0.1

8.0

219

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

2.9

8.0

111

F01.39

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without information on additional symptoms

41.8

8.0

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

0.5

8.0

987

S01.8

ICD-10 Finland

Open wound of other parts of head

1.8

8.0

108

494

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.4

8.0

421

2620

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

1.5

8.0

259

1479

128

Kela drug reimbursment

Cancers of female genital organs

0.3

7.9

637

Z10.1

ICD-10 Finland

Routine general health check-up of inhabitants of institutions

6.4

7.9

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

0.7

7.9

202

2540

R18

ICD-10 Finland

Ascites

0.4

7.9

923

GD1AA

NOMESCO Finland

Thorax X-ray examination

0.9

7.8

3694

33304

WX872

NOMESCO Finland

Intensive care

0.6

7.8

180

2316

K90

ICPC

Stroke/cerebrovascular accident

1.4

7.8

286

1671

F0029, G301,

ICD-10 Finland

75.4

7.8

S52.0

ICD-10 Finland

Fracture of upper end of ulna

1.8

7.8

109

504

A05

ICPC

Feeling ill

1.5

7.8

268

1548

F0020, G309,

ICD-10 Finland

+∞

7.8

F0024, G309,

ICD-10 Finland

+∞

7.8

F0012, G308,

ICD-10 Finland

+∞

7.8

F0003, G300,

ICD-10 Finland

+∞

7.8

F0289, G318,

ICD-10 Finland

+∞

7.8

R4120

NOMESCO Finland

Occupational therapy

0.7

7.8

196

2473

I68.0

ICD-10 Finland

Cerebral amyloid angiopathy

11.7

7.8

N02AA01

ATC

morphine; systemic, rectal

1.5

7.7

224

1249

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

0.8

7.7

509

5474

R63.4

ICD-10 Finland

Abnormal weight loss

1.4

7.7

321

1920

XF404

NOMESCO Finland

Ambulatory ECG

0.8

7.7

452

4939

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

0.2

7.7

482

XF606

NOMESCO Finland

Ortostatic test

2.1

7.7

301

P12

ICPC

Bedwetting/enuresis

16.7

7.7

S01.41

ICD-10 Finland

Open wound in the temple-jaw region

2.1

7.6

296

E53.8

ICD-10 Finland

Deficiency of other specified B group vitamins

2.2

7.6

225

ZYC01, ,

SPAT

1.3

7.6

487

3118

GD1LA

NOMESCO Finland

0.4

7.6

721

JN4CD

NOMESCO Finland

Very extensive body CT

0.6

7.5

136

1848

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.2

7.5

1628

11890

G20

ICD-10 Finland

Parkinson disease

1.5

7.5

263

1524

H25.1

ICD-10 Finland

Senile nuclear cataract

1.1

7.5

3741

28966

L02BG04

ATC

letrozole; oral

0.7

7.5

190

2395

WVA40, ,

SPAT

2.3

7.5

200

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

0.2

7.5

446

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

0.6

7.5

137

1855

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.9

7.5

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

6.4

7.5

ZYY02, ,

SPAT

7.5

A88

ICPC

Adverse effect physical factor

10.7

7.5

G40

ICD-10 Finland

Epilepsy

2.6

7.4

135

SPAT1142

SPAT

Minor procedure on teeth, gums, mouth and pharynx

3.5

7.4

F01.21

ICD-10 Finland

Subcortical vascular dementia without additional symptoms, mainly paranoidism

27.9

7.4

L01

ICPC

Neck symptom/complaint

0.8

7.4

586

6156

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

0.7

7.4

344

3887

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

0.4

7.4

771

I10

ICD-10 Finland

Essential (primary) hypertension

1.1

7.4

6071

48440

R03BB04

ATC

tiotropium bromide; inhalant

0.8

7.4

739

7557

K05.30

ICD-10 Finland

Periodontitis complex

0.8

7.3

563

5940

NA3BG, ,

SPAT

0.4

7.3

673

G47.3

ICD-10 Finland

Sleep apnoea

0.8

7.3

773

7864

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

0.4

7.3

660

SPAT1293

SPAT

Other function in accordance with rehabilitation guidance nomenclature

2.4

7.3

166

R26

ICD-10 Finland

Abnormalities of gait and mobility

3.3

7.3

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.4

7.3

377

2340

SPAT1165

SPAT

Peritoneal dialysis

3.3

7.3

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

1.6

7.2

159

833

L02BB04

ATC

enzalutamide; oral

0.3

7.2

517

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

0.5

7.2

1250

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

1.5

7.2

190

1038

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.2

7.2

236

3639

FHL

Other measure in this category

3.2

7.2

L04AX01

ATC

azathioprine; systemic

0.5

7.2

1247

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.1

7.2

253

NFB41, ,

NOMESCO Finland

0.0

7.2

177

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

0.7

7.2

220

2668

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

1.8

7.1

427

OAB48, ,

SPAT

0.4

7.1

830

N88

ICPC

Epilepsy

2.8

7.1

100

R03BA08

ATC

ciclesonide; inhalant

0.7

7.1

244

2899

F01.31

ICD-10 Finland

Mixed cortical and subcortical vascular dementia other additional symptoms, mainly paranoidism

37.6

7.1

SGB30

NOMESCO Finland

Other complicated root filling

0.6

7.1

107

1519

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.4

7.1

174

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

0.2

7.1

321

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

0.5

7.1

1283

WX212

NOMESCO Finland

Femoral plexus blockade

1.5

7.0

207

1159

P27

ICPC

Fear of mental disorder

2.6

7.0

129

SPAT1154

SPAT

Insertion or removal of subcutaneous medicine capsule

3.1

7.0

P69

ICPC

Psychological, Other reason for encounter NEC

7.4

7.0

DFF00, ,

SPAT

0.3

7.0

534

359

Kela drug reimbursment

Mirabegroni

2.3

7.0

201

S22.4

ICD-10 Finland

Multiple fractures of ribs

1.6

7.0

164

873

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

0.5

7.0

1269

N03AX09

ATC

lamotrigine; oral

1.8

7.0

105

497

D07CC01

ATC

betamethasone and antibiotics; topical

1.2

7.0

744

5083

R5140

NOMESCO Finland

Monitoring the use of the aid

0.8

6.9

398

4362

HAB40

NOMESCO Finland

Wedge excision of mammary gland

0.6

6.9

135

1800

S08

ICPC

Skin colour change

0.7

6.9

227

2720

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

0.4

6.9

629

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

0.7

6.9

197

2422

R053, ,

ICD-10 Finland

0.4

6.9

641

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

0.3

6.9

476

163

Kela drug reimbursment

Abiraterone and enzalutamide

0.3

6.9

566

P71

ICPC

Organic psychosis other

15.3

6.9

Q90.9

ICD-10 Finland

Down syndrome, unspecified

67.0

6.9

N30

ICPC

Neurological, Medical examin/health eval complete

67.0

6.9

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

1.5

6.9

199

1112

F32.1

ICD-10 Finland

Moderate depressive episode

1.7

6.8

120

594

N05AX16

ATC

brexpiprazole; oral

7.8

6.8

X31

ICD-10 Finland

Exposure to excessive natural cold

3.2

6.8

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

0.6

6.8

105

1481

F06.30

ICD-10 Finland

Organic manic syndrome

+∞

6.8

F0009, G301,

ICD-10 Finland

+∞

6.8

F0029, G309,

ICD-10 Finland

+∞

6.8

F0014, G308,

ICD-10 Finland

+∞

6.8

F0280, G318,

ICD-10 Finland

+∞

6.8

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

0.7

6.8

179

2236

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

0.6

6.8

1374

R21

ICPC

Throat symptom/complaint

0.8

6.8

488

5187

SPAT1107

SPAT

Extensive external surface anaesthesia of skin with cream or gel

2.6

6.8

122

A01

ICPC

Pain general/multiple sites

1.2

6.7

718

4903

R03BA02

ATC

budesonide; inhalant

0.8

6.7

844

8436

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

0.7

6.7

169

2131

ZXE30

NOMESCO Finland

More than five and less than seven hours

0.7

6.7

173

2171

ZXY02

NOMESCO Finland

Neuropsychologist

3.9

6.7

R96

ICPC

Asthma

0.8

6.7

389

4256

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

0.5

6.7

1167

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

0.8

6.7

789

7936

N05CD08

ATC

midazolam; nasal, systemic

1.5

6.7

197

1104

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

0.9

6.7

2468

22660

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

0.7

6.7

245

2878

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.4

6.7

163

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

1.4

6.7

249

1462

WX290

NOMESCO Finland

Other blockage of nerve

0.9

6.7

1448

13799

F22.8

ICD-10 Finland

Other persistent delusional disorders

5.8

6.7

G04BD04

ATC

oxybutynin; oral, transdermal

1.3

6.7

515

3385

WX730

NOMESCO Finland

Conventional respirator

0.4

6.7

679

Z01.9

ICD-10 Finland

Special examination, unspecified

1.4

6.7

356

2222

R40.2

ICD-10 Finland

Coma, unspecified

1.9

6.6

336

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.3

6.6

497

3255

T82

ICPC

Obesity

0.3

6.6

516

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

0.3

6.6

451

F01.80

ICD-10 Finland

Other specified vascular dementia without additional symptoms

11.2

6.6

A10BJ06

ATC

semaglutide; parenteral

0.5

6.6

1051

D07BC01

ATC

betamethasone and antiseptics; topical

1.2

6.6

808

5603

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

4.0

6.6

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.0

6.6

268

R12

ICD-10 Finland

Heartburn

0.7

6.6

256

2974

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

1.8

6.5

397

L02BA03

ATC

fulvestrant; parenteral

0.1

6.5

227

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

0.4

6.5

672

N05AN01

ATC

lithium; oral

2.0

6.5

286

X59.0

ICD-10 Finland

Exposure to unspecified factor causing fracture

5.6

6.5

E44.1

ICD-10 Finland

Mild protein-energy malnutrition

5.6

6.5

Z59.8

ICD-10 Finland

Other problems related to housing and economic circumstances

4.3

6.5

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

0.3

6.5

420

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

0.2

6.5

276

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.2

6.5

682

4652

NB6AA

NOMESCO Finland

Humerus X-ray examination

1.5

6.5

168

917

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.5

6.5

130

SPAT1042

SPAT

Guidance concerning balance maintenance

2.2

6.5

203

J01FA09

ATC

clarithromycin; systemic

0.9

6.5

1286

12340

62670

ICD-8 Finland

Disorders of menstruation, Postmenopausal bleeding

1.7

6.4

102

491

A12AA04

ATC

calcium carbonate; oral

0.4

6.4

751

L02BG06

ATC

exemestane; oral

0.3

6.4

547

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.3

6.4

361

2271

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

0.7

6.4

199

2407

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

0.2

6.4

221

GBB00

NOMESCO Finland

Tracheostomy

0.3

6.4

495

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

0.7

6.4

152

1937

UKC02

NOMESCO Finland

Cystoscopy

1.2

6.4

1644

12158

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

0.8

6.4

894

8843

K04

ICPC

Palpitations/awareness of heart

0.7

6.4

170

2117

N02BF02

ATC

pregabalin; oral

0.7

6.4

193

2345

A06AC01

ATC

ispaghula (psylla seeds); oral

1.1

6.4

2119

15957

T11

ICPC

Dehydration

3.6

6.3

115

Kela drug reimbursment

Breast cancer

0.7

6.3

303

3407

QDB10, ,

SPAT

0.6

6.3

1146

GX1C5, ,

SPAT

0.1

6.3

181

6271A

ICD-9 Finland

Menopausal and postmenopausal disorders, Postmenopausal bleeding

1.6

6.3

128

659

E66.01

ICD-10 Finland

Obesity due to excess calories

0.6

6.3

121

1617

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

0.7

6.3

341

3766

NG1EA, ,

SPAT

0.2

6.3

252

D07AC01

ATC

betamethasone; topical

1.1

6.3

2562

19541

A86

ICD-10 Finland

Unspecified viral encephalitis

2.8

6.3

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

0.2

6.3

234

HA1AA, ,

SPAT

0.4

6.3

564

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.1

6.3

1893

14161

F32.0

ICD-10 Finland

Mild depressive episode

1.8

6.3

446

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

0.7

6.2

272

3103

D01AE15

ATC

terbinafine; topical

1.3

6.2

506

3349

D12

ICPC

Constipation

1.4

6.2

309

1908

I21.2

ICD-10 Finland

Acute transmural myocardial infarction of other sites

0.3

6.2

422

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

1.8

6.2

368

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.5

6.2

123

SPAT1062

SPAT

Lung clearance therapy

2.5

6.2

128

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.4

6.2

230

1352

G04BD09

ATC

trospium; oral

1.5

6.1

204

1173

EBA00

NOMESCO Finland

Extraction of tooth

1.1

6.1

2056

15487

SPAT1359

SPAT

Use of symptom diary

1.6

6.1

148

796

TK800

NOMESCO Finland

Hemodialysis

0.5

6.1

803

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

0.6

6.1

1218

L01CB01

ATC

etoposide; systemic

0.1

6.1

197

OAB43, ,

SPAT

0.4

6.1

605

J01MA06

ATC

norfloxacin; oral

1.2

6.1

995

7092

Z02.8

ICD-10 Finland

Other examinations for administrative purposes

2.3

6.1

160

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

0.7

6.1

279

3155

U08

ICPC

Urinary retention

1.5

6.1

192

1094

F01.23

ICD-10 Finland

Subcortical vascular dementia other additional symptoms, mainly depression

18.8

6.1

N05AA02

ATC

levomepromazine; systemic

1.5

6.1

208

1204

4402A

ICD-9 Finland

Atherosclerosis, Of native arteries of the extremities

0.5

6.1

968

-1, ,

ICD-10 Finland

1.7

6.0

100

488

JAH01

NOMESCO Finland

Laparoscopy

0.6

6.0

1236

L02BB03

ATC

bicalutamide; oral

0.7

6.0

190

2290

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

9.1

6.0

C09CA06

ATC

candesartan; oral

0.9

6.0

1252

11977

W10

ICD-10 Finland

Fall on and from stairs and steps

1.3

6.0

335

2106

AA1XD

NOMESCO Finland

Other special CT of head and brain

2.6

6.0

105

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

372

157

20.57

307.65

1.0

415.07

238.52

ng/l

12.75

243

(3019309) Folate [Moles/volume] in Red Blood Cells

3712

14792

2.79

307.65

2.1

1.8

1375.37

1140.72

nmol/l

36.80

2622

10840

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

378

157

20.92

307.65

1.0

554.03

823.48

ng/l

7.01

238

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

378

157

20.92

307.65

1.0

56.29

29.68

ng/l

14.26

248

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3339

15013

2.32

297.82

2.0

1.8

3665954.94

25571920.66

pmol/l

3.87

2619

11724

(3029937) Albumin [Presence] in Urine by Test strip

3576

18905

1.93

187.81

5.5

4.8

0.00

estimate

1.34

1044

6405

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4140

23601

1.82

165.89

5.5

4.9

1.29

0.90

estimate

0.20

958

5853

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

449

883

4.41

164.15

1.2

1.3

474.91

638.75

mg/l

6.07

408

853

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

396

727

4.71

157.33

1.3

14.46

37.91

e6/l

0.94

335

543

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

392

732

4.63

152.58

1.3

1.4

279.01

1304.77

e6/l

2.51

346

581

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

400

761

4.54

152.22

1.2

3.93

3.89

mmol/l

0.25

379

711

(3009466) Valproate [Moles/volume] in Serum or Plasma

296

460

5.52

141.50

3.2

3.5

313.03

323.56

umol/l

0.49

228

379

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4640

28337

1.72

137.69

5.2

4.9

52.93

107.84

ng/l

2.21

3930

23518

(3019150) Specific gravity of Urine by Refractometry

2633

14136

1.77

119.59

5.8

5.0

1.02

1.22

kg/l

0.80

1627

9781

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1388

20221

0.50

118.95

1.7

1.9

1.23

1.24

mmol/l

0.42

1086

16125

(3031040) Bacteria [#/volume] in Urine by Automated count

6203

42697

1.61

99.59

6.9

5.9

3288.42

1634.59

e6/l

2.18

371

705

(3015377) Calcium [Moles/volume] in Serum or Plasma

3809

23461

1.59

97.60

2.5

3.4

2.35

mmol/l

1.89

3319

20696

(3026008) Bacteria identified in Urine by Culture

3985

24882

1.58

95.79

4.1

3.9

—

(3044290) Cell count panel - Cerebral spinal fluid

313

707

3.79

94.91

1.2

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

3523

21717

1.56

87.08

1.9

1.8

20.40

20.07

nmol/l

0.51

2996

18043

(40768804) Tissue Pathology biopsy report

1959

24053

0.60

84.17

2.2

2.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1584

8111

1.76

80.37

10.1

9.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2553

14923

1.59

77.41

2.9

3.1

2.46

2.48

mmol/l

9.04

2293

13035

(3035350) Ketones [Presence] in Urine by Test strip

4840

32565

1.49

75.71

5.4

4.7

1.16

3.19

estimate

0.85

1250

7589

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4070

26437

1.50

75.68

2.3

2.4

77.50

81.63

nmol/l

16.31

3375

22777

(3021601) Nitrite [Presence] in Urine by Test strip

4770

32148

1.48

72.84

5.4

4.7

0.00

estimate

0.07

1182

7270

(3009261) Glucose [Presence] in Urine by Test strip

4822

32793

1.46

68.63

5.4

4.7

0.02

0.30

estimate

0.81

1168

7142

(3041096) Erythrocytes [Presence] in Urine by Automated

2654

16050

1.53

67.40

4.8

4.4

0.92

0.48

estimate

0.43

911

5570

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1232

6181

1.76

66.01

3.4

4.1

1.23

1.22

mmol/l

2.81

996

5310

(3033658) Prothrombin time (PT) actual/Normal

1291

16669

0.59

63.67

3.2

4.3

78.80

80.31

1.31

1237

16350

(3015736) pH of Urine

3945

26187

1.44

61.23

4.8

4.1

6.32

6.33

0.20

2210

13833

(3023368) Bacteria identified in Blood by Culture

3538

23083

1.45

59.84

4.0

4.5

—

(3012516) Albumin [Mass/volume] in Urine

2059

23383

0.66

55.47

2.8

3.4

68.71

54.25

mg/l

0.79

1314

15269

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7195

53895

1.47

53.64

21.8

22.3

30.77

29.63

mg/l

1.74

6443

47037

(3009508) Creatinine [Moles/volume] in Urine

2081

23429

0.67

52.98

2.8

3.4

6.80

6.54

mmol/l

2.09

1626

19093

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2317

14192

1.48

52.94

2.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3441

22713

1.42

52.66

2.5

2.2

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5130

36369

1.39

50.81

5.5

7.3

1.22

1.21

mmol/l

14.30

4042

30949

(3024561) Albumin [Mass/volume] in Serum or Plasma

4604

32074

1.39

50.62

3.8

4.8

34.05

33.86

g/l

1.33

4036

29637

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3310

21854

1.41

49.82

2.4

2.2

265.38

213.32

u/l

2.52

3053

20420

(3020682) Albumin/Creatinine [Ratio] in Urine

2179

24034

0.69

48.58

3.5

4.2

9.93

10.17

mg/mmol

0.08

1362

15100

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

169

402

3.56

47.62

2.4

2.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4474

31332

1.36

45.77

2.5

2.3

90.37

93.39

pmol/l

4.00

2426

16270

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5564

40584

1.35

42.07

4.1

4.4

15.52

15.31

pmol/l

6.98

4730

35886

(3051387) C reactive protein [Mass/volume] in Capillary blood

391

1553

2.15

41.23

3.8

3.9

31.54

31.21

mg/l

0.05

311

1149

(3019550) Sodium [Moles/volume] in Serum or Plasma

7317

55859

1.40

40.61

26.9

28.1

139.65

139.32

mmol/l

15.65

7012

54611

(3023103) Potassium [Moles/volume] in Serum or Plasma

7319

55890

1.40

40.43

26.9

28.3

4.02

4.03

mmol/l

0.92

7000

54573

(3010813) Leukocytes [#/volume] in Blood

7346

56177

1.40

39.79

31.4

33.8

7.35

7.16

e9/l

4.11

7001

54305

(4035726) Immunohistochemistry procedure

374

6103

0.49

39.39

1.3

1.4

—

(3026361) Erythrocytes [#/volume] in Blood

7341

56166

1.40

39.32

31.4

33.8

4.20

4.28

e12/l

29.84

6996

54279

(3024731) MCV [Entitic mean volume] in Red Blood Cells

7341

56167

1.40

39.31

31.3

33.7

92.04

92.12

0.75

7065

55162

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

7341

56167

1.40

39.31

31.6

34.3

38.09

38.62

11.92

7056

55121

(3014271) Vancomycin [Susceptibility]

192

557

2.92

39.31

3.4

3.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

7341

56172

1.40

39.24

31.7

34.1

126.72

128.87

g/l

27.98

7067

55190

(3007461) Platelets [#/volume] in Blood

7340

56164

1.40

39.23

31.4

33.8

236.65

236.02

e9/l

0.32

7011

54558

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4572

32582

1.33

39.21

5.1

6.6

1.21

mmol/l

3.38

3948

29747

(3035941) MCH [Entitic mass]

7340

56166

1.40

39.20

31.3

33.7

30.37

30.42

1.05

7061

55162

(3020564) Creatinine [Moles/volume] in Serum or Plasma

7328

56099

1.39

38.64

28.3

30.7

87.48

89.70

umol/l

4.91

7042

55085

(3037467) Urinalysis macro (dipstick) panel - Urine

5729

42335

1.33

37.25

5.7

5.4

3.17

1.88

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1294

7516

1.51

36.77

2.7

2.5

5.27

6.29

ug/l

1.29

890

6387

(3000492) Spirometry study

211

4142

0.41

36.53

1.4

1.6

—

(3018405) Lactate [Moles/volume] in Arterial blood

571

2749

1.78

34.35

2.7

3.8

1.47

1.43

mmol/l

0.26

558

2687

(3013826) Glucose [Moles/volume] in Serum or Plasma

5309

39196

1.30

32.39

5.0

5.2

7.16

6.92

mmol/l

9.41

5081

37440

(3022096) Basophils/Leukocytes in Blood

2879

28999

0.76

31.85

4.8

6.1

0.58

0.62

2.26

2573

26814

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

423

6207

0.55

31.24

2.2

2.4

44.60

39.27

u/l

0.17

340

5179

(3002030) Lymphocytes/Leukocytes in Blood

2924

29316

0.76

30.96

4.7

6.1

23.77

24.49

2.57

2688

27405

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6464

49125

1.31

30.92

5.4

5.6

2.08

2.14

mu/l

1.87

5571

43830

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1026

12165

0.67

30.80

3.7

3.5

2.76

2.73

e6/l

0.04

591

6399

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

126

4.81

30.37

2.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

327

5138

0.52

30.30

4.6

7.2

24.08

24.28

mmol/l

0.41

302

4945

(3002256) Pathology report gross observation

696

8909

0.63

29.99

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

562

2801

1.72

29.92

1.2

—

(3032080) INR in Blood by Coagulation assay

4931

36260

1.28

29.91

21.0

22.7

1.42

1.43

inr

0.28

4331

30786

(3006504) Eosinophils/Leukocytes in Blood

2896

28971

0.76

29.75

4.7

6.0

2.73

2.76

0.18

2589

26762

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1280

7723

1.45

29.53

5.0

4.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

629

8212

0.62

29.49

1.2

1.3

12.96

14.96

u/ml

0.28

248

2687

(3018010) Neutrophils/Leukocytes in Blood

2851

28552

0.76

29.43

4.6

6.0

60.85

59.91

3.46

2615

26950

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

150

4.38

29.42

1.4

1.2

34.20

66.91

—

(3019069) Monocytes/Leukocytes in Blood

2908

29042

0.77

29.37

4.8

6.2

9.14

9.28

1.44

2602

26800

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

125

4.71

28.86

2.0

—

(3020891) Body temperature

720

3866

1.60

28.72

3.3

4.4

36.94

36.90

°c

2.42

709

3817

(3040151) Glucose [Moles/volume] in Capillary blood

260

1022

2.16

28.19

8.4

9.3

8.38

7.21

mmol/l

1.39

215

846

(3018418) pH of Serum or Plasma

3156

22042

1.29

28.16

3.3

4.3

7.40

2.50

2422

16091

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1155

13127

0.70

27.13

3.4

1.85

1.45

e6/l

0.82

723

7373

(3008152) Bicarbonate [Moles/volume] in Arterial blood

907

5208

1.50

26.75

4.8

6.3

24.26

24.50

mmol/l

1.09

885

4984

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

699

8731

0.64

26.71

1.2

1.3

46.01

44.33

iu/ml

0.08

197

2636

(3037522) Nuclear Ab [Titer] in Serum

500

6739

0.60

26.60

1.3

476.12

502.27

titre

0.13

103

1629

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1065

6328

1.46

26.46

3.4

2.6

0.55

0.53

e6/l

0.08

1037

6126

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2968

20788

1.28

25.19

2.4

2.6

60.07

62.99

u/l

0.93

2678

19068

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

746

9026

0.66

24.24

2.8

3.8

22.46

27.09

ug/l

0.20

590

7640

(40761536) Microorganisms panel - Urine sediment

883

5165

1.47

23.66

5.3

4.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

787

9325

0.68

22.85

1.6

1.5

2.94

2.78

g/l

0.62

447

5050

(3023410) Appearance of Cerebral spinal fluid

109

316

2.91

22.52

1.2

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

594

7410

0.65

22.30

2.2

2.5

10.43

10.62

umol/l

0.06

458

6513

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2991

21248

1.26

21.80

2.4

2.5

3.22

3.10

mg/l

1.59

2411

18156

(3001604) Monocytes [#/volume] in Blood

3215

30959

0.80

21.49

4.3

5.7

0.63

0.65

e9/l

2.13

2749

25717

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1522

9935

1.33

21.25

1.9

—

(3006315) Basophils [#/volume] in Blood

3238

31126

0.80

21.20

4.3

5.7

0.04

e9/l

2.39

2767

25914

(3020779) Urea [Moles/volume] in Serum or Plasma

655

7888

0.67

20.55

4.5

5.9

11.86

12.59

mmol/l

1.46

580

7404

(4034850) Laboratory test

361

1775

1.73

20.18

10.0

14.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1616

10715

1.31

20.10

1.9

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

178

2987

0.49

20.06

1.8

2.9

545.48

3812.23

u/ml

1.89

141

2543

(3013115) Eosinophils [#/volume] in Blood

3340

31864

0.81

19.89

4.4

5.9

0.20

e9/l

0.01

2807

26933

(3044242) Glucose [Moles/volume] in Arterial blood

141

502

2.37

19.45

1.7

1.8

9.22

7.95

mmol/l

1.42

141

502

(3003694) ABO and Rh group [Type] in Blood

1317

13989

0.75

19.16

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

1533

15947

0.77

19.10

3.8

3.7

0.24

0.08

1.65

697

(3026493) Urate [Moles/volume] in Serum or Plasma

1694

17396

0.77

19.08

2.5

3.1

356.71

370.12

umol/l

4.62

1313

14630

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

142

2531

0.46

19.02

1.5

2.3

0.00

g/l

-0.00

123

2349

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

516

2828

1.56

18.77

1.6

1.5

1.65

1.66

0.00

413

2233

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

160

2698

0.49

18.30

1.6

2.3

0.00

g/l

0.73

123

2355

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1626

16654

0.78

17.71

2.3

2.7

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

102

327

2.63

17.56

1.2

2.02

2.31

mmol/l

2.64

291

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

529

2961

1.52

17.49

2.0

1.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

563

3199

1.50

17.33

2.1

2.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

173

2790

0.51

17.29

1.5

2.3

0.03

0.04

g/l

0.14

140

2492

(3019198) Lymphocytes [#/volume] in Blood

3338

31559

0.82

17.25

4.4

5.8

1.70

1.85

e9/l

4.14

2883

26922

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

949

10396

0.74

16.86

2.9

3.8

244.95

251.33

u/l

0.69

812

9748

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1451

14993

0.78

16.83

4.6

4.7

122.52

465.64

ng/l

6.16

1282

13578

(3022145) Colonoscopy Study observation

562

6713

0.68

16.73

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

324

4339

0.61

16.56

1.3

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

358

4644

0.63

15.93

1.3

1.5

—

(40768797) Stomach Pathology biopsy report

777

8698

0.72

15.82

1.2

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

274

3766

0.60

15.58

1.3

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

290

3920

0.61

15.40

1.6

2.3

3.75

3.67

g/l

0.30

223

3492

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

281

2.63

15.33

1.8

2.5

4.87

5.02

kpa

0.49

281

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

282

2.62

15.23

1.8

2.5

9.64

9.96

kpa

0.51

282

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

294

3930

0.61

14.90

1.6

2.3

7.47

7.52

g/l

0.21

224

3502

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

294

3928

0.61

14.87

1.6

2.3

4.17

4.15

g/l

0.15

224

3505

(40758558) Short blood count panel - Blood

1827

18115

0.81

14.47

5.2

6.6

—

(3021589) Normoblasts [#/volume] in Blood

2753

26171

0.83

14.15

14.8

13.4

0.00

e9/l

0.48

2368

21031

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1777

17628

0.81

14.07

2.6

3.1

33.60

36.41

u/l

1.44

1621

16372

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

341

4342

0.64

13.92

1.3

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1688

0.44

13.91

1.8

2.0

3.61

3.67

g/l

0.14

1594

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

257

3478

0.61

13.72

1.5

2.3

10.36

10.41

g/l

0.05

181

3007

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5990

46829

1.19

13.63

5.8

8.5

81.88

85.74

u/l

4.01

5386

44093

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

352

4428

0.65

13.57

1.3

1.5

—

(3036489) Thrombin time

129

2108

0.50

13.49

1.6

1.7

20.45

21.71

1.34

109

1944

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

274

3618

0.62

13.18

1.6

2.3

2.76

2.99

g/l

2.95

204

3189

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

176

2600

0.56

13.17

2.1

4.3

211.29

107.52

u/ml

0.97

163

2478

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1022

10736

0.77

13.14

3.7

5.3

1.02

1.05

mmol/l

3.29

866

9804

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

251

3363

0.61

12.86

1.7

2.4

1.73

1.18

g/l

0.78

179

2810

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

253

3380

0.62

12.80

2.0

2.5

0.36

0.35

iu/ml

0.29

144

1892

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

112

436

2.16

12.69

1.5

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

361

4451

0.67

12.60

1.4

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

196

933

1.77

12.42

1.1

1.2

—

(3000991) Gas panel - Venous blood

646

7178

0.73

12.39

3.8

7.1

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

28.47

12.33

1.0

10662.73

—

ng/l

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

719

4560

1.34

11.90

3.4

4.3

43.20

45.31

1.57

713

4495

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

369

4472

0.68

11.79

5.9

8.1

15.79

15.60

0.70

354

4319

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

3488

26284

1.17

11.75

3.7

3.8

—

2.52

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1348

13544

0.80

11.72

3.0

3.7

0.90

0.91

ug/l

0.06

925

10112

(3028026) IgM [Mass/volume] in Serum or Plasma

262

3397

0.63

11.64

2.1

1.9

1.86

1.42

g/l

0.78

206

3027

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

855

0.29

11.60

1.5

1.8

3.22

3.12

mmol/l

0.19

634

(40768443) Skin Pathology biopsy report

244

3212

0.63

11.60

1.2

—

(3000850) Epithelial cells [#/volume] in Urine

2361

17234

1.19

11.56

3.2

2.9

6.21

4.93

e6/l

5.35

2226

15631

(3000494) Fungus identified in Specimen by Culture

614

6805

0.74

11.56

1.4

—

(36660697) Celiac disease serology panel - Serum

288

3652

0.65

11.54

1.3

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

131

2013

0.54

11.29

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

104

413

2.12

11.26

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

184

2559

0.59

11.02

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

319

3919

0.67

10.95

1.3

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3171

29338

0.86

10.92

2.6

3.0

—

estimate

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

5500

43058

1.16

10.91

4.1

4.8

15.94

16.55

mm/h

1.74

4753

39399

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

118

1847

0.53

10.83

1.5

1.6

35.39

32.94

u/ml

0.07

265

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

4.26

10.82

1.0

1.1

15.67

57.42

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

3837

34974

0.86

10.79

5.7

8.8

4.83

4.51

e9/l

8.46

3327

29719

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1422

0.47

10.79

1.3

1.2

2.65

5.14

u/ml

1.25

238

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1263

12669

0.81

10.71

2.4

2.8

19.36

20.35

1.96

1032

11647

(3044640) Blood type and Crossmatch panel - Blood

2338

22109

0.85

10.48

2.3

2.7

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1417

0.47

10.46

1.3

1.2

1.77

6.31

u/ml

—

147

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1484

0.49

10.22

1.3

1.2

3.00

39.57

u/ml

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6896

55062

1.17

10.04

10.1

13.7

21.91

23.21

u/l

1.88

6348

52742

(3023420) DNA double strand Ab [Units/volume] in Serum

147

2109

0.58

9.97

2.0

1.6

7.03

8.20

iu/ml

0.25

489

(4094501) Cardiovascular stress test using bicycle ergometer

1356

0.48

9.91

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

979

0.40

9.56

3.1

3.6

—

(3012501) Base excess in Blood by calculation

305

1740

1.48

9.33

3.7

4.7

2.58

2.90

mmol/l

1.01

201

1193

(3017446) Testosterone [Moles/volume] in Serum or Plasma

284

3456

0.68

9.31

1.8

2.1

10.18

10.60

nmol/l

0.36

231

2884

(3013290) Carbon dioxide [Partial pressure] in Blood

305

1742

1.48

9.28

3.7

4.7

4.97

5.03

kpa

0.63

292

1688

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1245

0.47

9.28

1.4

1.2

0.93

6.70

u/ml

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

3.68

8.97

15.4

11.8

0.64

0.65

mmol/l

0.08

(3027315) Oxygen [Partial pressure] in Blood

304

1750

1.47

8.91

3.8

4.7

7.89

8.24

kpa

3.87

290

1696

(3005719) IgG [Mass/volume] in Serum or Plasma

365

4205

0.71

8.79

3.2

2.8

10.95

10.88

g/l

0.08

312

3825

(40760892) CBC W Ordered Manual Differential panel - Blood

1608

11593

1.19

8.76

3.9

4.7

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

346

2.06

8.74

1.1

—

4.32

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

447

2770

1.37

8.64

1.8

2.1

791.17

620.16

ug/l

0.40

412

2652

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

174

2305

0.62

8.59

1.4

1.6

39.25

38.74

u/l

0.08

134

1926

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

425

4758

0.74

8.54

2.6

3.6

24.22

24.08

mmol/l

0.45

411

4669

(3020191) Ethanol [Moles/volume] in Serum or Plasma

246

2.25

8.46

1.1

1.2

0.94

0.90

promille

0.10

188

(3023199) Leukocytes [#/volume] in Pleural fluid

1498

0.54

8.41

1.3

1.5

1279.97

2423.08

e6/l

1.08

1069

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

431

4793

0.74

8.29

1.5

1.7

1.62

1.55

g/l

0.80

321

4104

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1115

0.48

8.26

1.3

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

172

2263

0.63

8.25

3.4

3.7

2.03

1.75

index

0.26

1184

(3003434) Protein [Mass/volume] in Pleural fluid

122

1745

0.58

8.25

1.3

1.5

29.56

30.20

g/l

0.25

105

1570

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

589

3832

1.30

8.19

1.7

1.8

2.70

2.44

ug/l

0.17

434

3333

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

203

2567

0.65

8.11

1.2

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

106

2.93

8.05

1.1

1.2

0.51

0.48

ratio

0.24

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1467

0.55

8.04

1.5

1.7

12.29

13.05

mg/l

0.32

1324

(40768806) Pleura Pathology biopsy report

1282

0.52

8.04

1.4

1.6

—

(3045788) Cell count panel - Pleural fluid

1192

0.50

8.01

1.4

1.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

455

4976

0.75

7.80

4.4

6.5

24.66

24.76

mmol/l

0.21

443

4923

(3019225) pH of Specimen

1032

7220

1.22

7.69

4.3

4.7

7.37

7.36

0.57

656

5110

(3007566) Smooth muscle Ab [Titer] in Serum

1294

0.53

7.65

1.1

101.82

138.92

titre

0.54

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1262

12287

0.84

7.63

2.2

2.7

0.82

mmol/l

0.06

1101

11346

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

478

0.24

7.59

1.6

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

478

0.24

7.59

1.6

1.3

—

(3036603) Volume of Urine

488

0.26

7.51

2.5

1.5

1389.60

1749.20

1.58

468

(3028308) Erythrocytes [#/volume] in Pleural fluid

1344

0.55

7.38

1.3

1.5

78406.80

55637.62

e6/l

0.29

762

(3027273) Bicarbonate [Moles/volume] in Venous blood

632

4211

1.27

7.32

2.8

3.5

25.38

25.03

mmol/l

1.92

614

4087

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

182

2.35

7.27

1.1

37.84

53.14

mg/l

1.36

154

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

962

0.47

7.24

1.4

1.2

36.91

48.75

u/ml

—

108

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5674

49715

0.89

7.19

4.5

5.4

1.45

1.44

mmol/l

1.36

4690

44113

(3024980) IgG subclass 4 [Mass/volume] in Serum

780

0.43

7.05

1.2

1.5

0.56

0.86

g/l

0.86

592

(3005570) Glucose [Moles/volume] in Urine

145

748

1.63

7.05

2.6

2.1

—

(40768793) Breast Pathology biopsy report

1313

0.56

7.01

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1409

13502

0.85

7.00

2.2

2.7

2.19

2.22

g/l

1.29

1166

12321

(3034770) Mitochondria Ab [Titer] in Serum

1317

0.56

6.89

1.1

—

831.71

titre

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

774

7822

0.81

6.89

3.6

3.4

226.23

301.10

ng/l

5.66

716

7220

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

3.47

6.87

1.6

2.8

129.53

129.62

nmol/l

0.00

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

189

2335

0.67

6.79

1.1

0.99

1.02

u/ml

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

167

2.36

6.79

3.3

2.7

25.68

29.54

umol/l

1.74

131

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1071

0.52

6.75

5.6

3.6

133.20

3042.64

iu/ml

—

149

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

571

0.35

6.70

2.1

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

274

3158

0.72

6.68

2.7

—

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

8.37

6.63

1.1

2.00

1.00

—

(1002224) Polysomnography panel

841

0.46

6.63

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

791

0.45

6.55

1.4

1.2

—

18.27

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

430

4625

0.77

6.55

1.3

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

274

2.02

6.54

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

661

0.40

6.53

1.1

1.2

—

(3010421) pH of Blood

405

2586

1.32

6.51

3.4

4.0

7.41

0.54

392

2539

(3048689) Calprotectin [Mass/mass] in Stool

538

5618

0.79

6.46

1.7

1.9

221.63

173.87

ug/g

1.16

366

4308

(3030467) Casts [#/volume] in Urine by Automated count

2286

21026

0.88

6.30

3.6

3.7

0.63

0.53

e6/l

1.34

1902

16033

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1224

11762

0.85

6.24

1.6

1.9

29.67

30.19

2.07

1169

11435

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5758

50228

0.90

6.18

4.5

5.5

4.26

4.27

mmol/l

0.32

4791

44991

(40767503) Oxygen content in Capillary blood by calculation

294

1803

1.37

6.17

2.5

2.7

16.15

15.67

2.09

288

1772

(3036782) Glucose [Moles/volume] in Pleural fluid

1123

0.55

6.11

1.2

1.4

6.40

6.42

mmol/l

0.02

1066

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1086

10509

0.85

6.03

1.2

1.45

1.64

u/ml

0.27

355

2435

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

6.28

5.97

1.1

1.2

13.38

15.50

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

5.27

5.92

1.1

1.2

55.67

44.67

—

(36304419) Bacteria [Presence] in Urine

2123

19539

0.88

5.83

3.5

3.7

3690.70

169.73

estimate

0.44

140

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

410

4364

0.78

5.78

2.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

792

7848

0.83

5.76

2.1

2.5

65.24

65.55

g/l

0.48

643

7016

(3005322) IgE [Units/volume] in Serum or Plasma

211

2470

0.71

5.70

1.2

1.3

303.78

247.13

u/ml

0.53

183

2253

(3006184) Hemoglobin [Mass/volume] in Capillary blood

331

2095

1.33

5.70

2.2

2.3

125.04

124.91

g/l

0.03

298

1623

(3045142) Bone marrow Pathology biopsy report

850

0.51

5.70

1.2

—

(3006270) Folate [Moles/volume] in Blood

117

606

1.62

5.68

1.3

1.2

311.55

310.40

nmol/l

0.02

435

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5475

47795

0.90

5.68

3.9

4.6

1.21

1.23

mmol/l

1.16

4449

41756

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

689

0.46

5.63

1.5

1.2

163.12

158.52

au/ml

0.09

207

(40768800) Prostate Pathology biopsy report

128

1631

0.65

5.44

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

801

0.51

5.39

1.4

1.2

—

(3042936) Bacteria identified in Isolate by Culture

1059

10175

0.85

5.36

1.8

2.0

—

(21494755) Public health laboratory ask at order entry panel

387

0.30

5.36

1.2

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

120

1542

0.65

5.32

1.6

1.5

0.46

7.93

iu/ml

1.27

394

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

436

0.34

5.31

1.1

1.2

—

110.00

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

119

1531

0.65

5.30

1.3

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

729

0.49

5.29

1.1

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

802

0.52

5.20

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

172

2.14

5.18

1.0

1.1

276.77

325.38

mg/l

0.97

149

(3003129) Base excess in Capillary blood by calculation

864

0.54

5.13

2.3

2.6

0.86

0.45

mmol/l

0.23

830

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

364

0.30

5.11

1.1

99.46

91.44

2.11

328

(3042111) Morphology [Interpretation] in Bone marrow Narrative

114

1463

0.65

5.04

1.4

—

(3025941) Bacteria identified in Stool by Culture

423

2819

1.27

4.99

1.4

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

126

1579

0.66

4.98

1.8

1.4

1.18

1.15

g/l

0.39

117

1493

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

553

0.44

4.96

1.2

7.40

2.31

u/ml

—

182

(40768441) Liver Pathology biopsy report

395

0.34

4.94

1.0

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

555

3818

1.23

4.93

3.6

4.4

1.49

1.52

0.41

538

3634

(43055442) Apixaban [Mass/volume] in Serum or Plasma

233

0.25

4.88

2.1

1.6

45.14

119.23

ug/l

—

198

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1103

0.60

4.86

1.3

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

848

6083

1.18

4.84

1.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

123

1539

0.66

4.83

1.8

1.4

0.23

g/l

0.09

115

1452

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

814

0.54

4.81

1.1

—

11.32

u/ml

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

162

2.12

4.73

1.4

1.5

17.77

16.78

pmol/l

0.48

123

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

199

0.21

4.72

1.2

1.3

1.57

1.51

g/l

—

199

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

1174

0.62

4.67

1.3

282.14

358.52

u/l

0.79

1116

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

344

0.32

4.63

1.7

2.2

—

(3024928) Oxygen saturation in Venous blood

163

1918

0.71

4.62

1.6

2.5

56.07

57.37

0.30

142

1820

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

109

589

1.55

4.52

1.2

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

207

0.24

4.52

1.5

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2039

15613

1.12

4.49

5.6

4.4

0.19

0.32

0.27

259

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

107

579

1.55

4.42

1.2

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

118

1453

0.67

4.32

1.5

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

159

1854

0.71

4.30

1.3

1.2

0.42

0.91

u/ml

1.22

170

(3048929) Epstein Barr virus Ab [Presence] in Serum

817

0.57

4.29

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

719

5142

1.18

4.27

1.7

2.2

397.93

394.37

nmol/l

0.17

608

4691

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

730

0.55

4.26

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

125

706

1.49

4.25

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

426

0.41

4.25

1.0

1.2

32.56

29.80

u/l

0.11

352

(3011985) Renin [Units/volume] in Plasma

782

0.56

4.23

1.2

1.3

61.39

57.84

mu/l

0.05

689

(3022948) Iron [Moles/volume] in Serum or Plasma

1553

14310

0.89

4.20

2.2

2.7

10.62

11.26

umol/l

3.27

1286

13150

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

152

1776

0.71

4.17

1.8

2.8

168.72

979.54

u/ml

3.31

129

1619

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

703

0.54

4.16

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

121

2.22

4.14

1.0

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

160

2.04

4.13

1.4

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

160

2.04

4.13

1.1

1.0

—

(3047189) Immunofixation for 24 hour Urine

420

0.42

4.12

1.0

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

524

0.48

4.12

1.1

1.2

2.85

4.96

u/ml

1.19

242

(3008116) Ketones [Moles/volume] in Urine by Test strip

138

2.12

4.10

1.2

1.5

0.17

0.23

mmol/l

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

201

1.92

4.09

1.2

1.4

103.31

74.67

umol/l

0.46

118

(4281824) Cell count and differential, peritoneal fluid

687

0.55

4.07

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

836

0.59

4.07

1.5

1.3

0.10

0.25

nmol/l

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

161

2.03

4.06

2.3

2.2

59.65

47.28

umol/l

1.22

132

(3023183) Ammonium ion [Moles/volume] in Plasma

205

1276

1.35

4.06

1.6

2.0

25.96

33.20

umol/l

4.28

172

1101

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

463

0.45

4.04

1.0

1.1

—

3.10

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5996

51744

0.92

3.99

5.1

6.5

2.39

mmol/l

0.27

5012

46200

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

133

1576

0.70

3.98

1.4

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

470

0.46

3.95

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

818

7821

0.86

3.88

4.3

5.5

34.65

34.31

0.30

391

4863

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1446

13320

0.89

3.87

1.5

1.6

1.87

1.70

mg/l

0.59

1111

10618

(3025130) Human papilloma virus identified in Specimen

273

0.31

3.85

1.5

1.6

—

(3017354) Segmented neutrophils/Leukocytes in Blood

915

0.62

3.82

3.6

3.7

56.05

59.29

0.38

762

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

737

0.58

3.81

1.0

1.2

58.26

60.05

u/l

0.10

649

(3014111) Lactate [Moles/volume] in Serum or Plasma

770

7383

0.86

3.80

3.2

5.9

1.48

1.41

mmol/l

1.12

739

7182

(3032057) Clostridioides difficile [Presence] in Stool

195

1.89

3.78

1.6

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1175

0.67

3.77

1.1

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

818

0.60

3.76

2.0

1.9

544.33

1673.07

u/ml

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

368

0.41

3.76

1.2

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

356

0.40

3.76

1.0

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

732

0.58

3.73

1.1

1.2

243.00

254.59

pmol/l

0.16

593

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

413

0.44

3.72

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

515

0.50

3.72

2.8

2.9

33.48

31.77

mg/l

0.09

405

(3021788) Differential panel - Synovial fluid

112

1349

0.69

3.70

1.5

—

1.00

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

404

1.60

3.70

2.4

2.0

2.41

2.65

u/field

0.11

260

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

2.85

3.66

1.2

21.56

11.82

pmol/l

0.84

(4268621) Lupus anticoagulant assay

363

0.41

3.65

1.8

2.2

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

216

1.82

3.63

1.4

72.55

59.85

1.92

187

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1065

0.66

3.63

1.2

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

301

0.36

3.61

1.4

1.1

0.08

0.93

u/ml

—

164

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

347

0.41

3.56

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

347

0.41

3.56

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

357

0.42

3.52

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

344

0.41

3.49

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

536

0.53

3.48

1.4

1.3

14.66

13.21

u/l

0.23

416

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

728

0.59

3.48

1.5

1.3

0.19

0.21

nmol/l

0.61

590

(3051611) Lipemic interference index of Serum or Plasma

811

0.62

3.48

3.4

12.06

12.01

index

0.01

419

(3035637) Corticotropin [Mass/volume] in Plasma

643

0.57

3.47

1.2

1.4

21.58

28.24

ng/l

1.59

643

(3008898) HLA-B27 [Presence]

757

0.61

3.44

1.0

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

343

3493

0.81

3.40

2.6

3.0

52.58

87.80

mg/l

1.15

266

2969

(4195642) Thrombophilia screening test

443

0.49

3.39

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3580

28462

1.08

3.38

3.4

3.7

1973.35

2246.38

ng/l

2.97

2975

25240

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

10.04

3.37

1.5

1.4

12.08

5.08

nmol/l

—

(3028717) Thiamine [Mass/volume] in Blood

2.79

3.34

1.1

59.50

62.56

ug/l

0.25

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

343

3485

0.82

3.33

2.6

3.0

41.62

57.60

mg/l

1.15

268

2962

(3029075) Extractable nuclear Ab panel - Serum

264

0.35

3.32

1.5

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

334

0.42

3.27

1.2

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

356

0.45

3.24

1.1

1.0

—

(3000330) Specific gravity of Urine by Test strip

423

4199

0.83

3.23

4.8

4.1

1.02

ratio

6.83

375

3811

(3018333) Ribosomal P Ab [Presence] in Serum

332

0.43

3.23

1.2

1.1

—

(3003181) Sodium [Moles/volume] in Urine

258

1716

1.26

3.23

1.3

62.21

59.22

mmol/l

0.65

207

1383

(3001729) Color of Synovial fluid

2.43

3.22

1.9

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

445

0.51

3.21

1.6

1.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

626

0.59

3.17

1.1

319.32

293.29

u/ml

0.22

355

(3008295) Osmolality of Serum or Plasma

132

802

1.38

3.14

1.3

276.24

273.45

mosm/kgh2o

0.59

101

575

(1616796) Gas panel - Central venous blood

293

1985

1.24

3.13

3.3

4.0

—

(3023419) Bacteria identified in Sputum by Culture

1068

0.69

3.10

1.8

2.4

—

(3006653) Thiamine [Moles/volume] in Blood

228

1.73

3.09

1.1

1.0

128.81

134.73

nmol/l

0.25

228

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.86

3.06

1.1

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

114

679

1.41

3.05

1.3

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

905

0.66

3.04

1.3

17.72

11.72

u/l

0.52

826

(3035880) pH of Pleural fluid

645

0.61

2.96

1.2

1.3

7.41

0.06

459

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

613

0.60

2.95

1.5

1.6

4.49

5.15

mg/l

0.63

578

(40757494) Bilirubin.total [Moles/volume] in Blood

375

1.54

2.93

1.5

2.1

19.46

27.42

umol/l

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

100

2.09

2.91

1.0

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

932

0.68

2.86

1.5

1.9

—

(3000285) Sodium [Moles/volume] in Blood

184

1.78

2.84

1.3

139.03

137.88

mmol/l

1.04

153

(3016650) Hepatitis A virus Ab [Presence] in Serum

667

0.62

2.81

1.1

1.0

—

(1175426) CD3 cells/Lymphocytes in Blood

347

0.48

2.81

3.2

1.7

63.05

70.39

1.18

320

(3006922) Hepatitis E virus Ab [Presence] in Serum

298

0.45

2.74

1.1

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.79

2.74

1.1

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

452

0.55

2.72

1.3

1.6

—

(3038026) Centromere Ab [Units/volume] in Serum

483

0.57

2.70

1.1

1.2

—

76.42

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

487

3515

1.17

2.69

3.7

4.5

0.86

0.85

0.33

469

3333

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

307

0.46

2.69

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

470

0.57

2.66

1.0

1.1

—

(3000012) Reticulocyte production index

225

1513

1.25

2.63

1.9

2.1

0.83

0.87

0.66

148

1075

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.03

2.61

1.2

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3859

30983

1.07

2.61

3.0

3.2

50.13

60.08

u/l

8.89

3328

27891

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

317

3158

0.83

2.58

2.5

2.9

4.37

9.00

ratio

0.61

210

1929

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

793

0.67

2.58

1.4

1.6

11.81

4.55

mg/l

1.46

626

(40757373) Influenza virus identified in Isolate

153

1.81

2.57

1.5

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

517

0.60

2.56

1.0

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

588

0.62

2.53

1.5

1.2

97.26

35.97

u/ml

—

(4062490) Immunoglobulin typing, IgG

472

0.58

2.50

1.2

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

119

1.90

2.46

1.0

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

151

976

1.30

2.46

1.3

1.4

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

2.45

0.0

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

174

0.38

2.43

2.5

2.3

4.00

250.11

ug/l

—

174

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

328

0.51

2.43

3.1

1.7

24.05

17.35

1.30

315

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

132

1436

0.77

2.41

1.2

142.61

286.59

titre

1.44

110

(3028192) IgG subclass 2 [Mass/volume] in Serum

477

0.59

2.41

1.1

1.3

2.95

2.89

g/l

0.05

347

(3024139) IgG subclass 3 [Mass/volume] in Serum

477

0.59

2.41

1.1

1.3

0.42

0.48

g/l

0.46

346

(3027135) IgG subclass 1 [Mass/volume] in Serum

477

0.59

2.41

1.1

1.3

6.64

7.04

g/l

0.19

344

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

671

6279

0.89

2.39

2.7

3.7

89.70

102.33

ng/l

3.08

472

5203

(3024354) Oxygen [Partial pressure] in Venous blood

963

7330

1.11

2.37

2.6

3.1

3.97

4.32

kpa

9.24

935

7101

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

109

1.92

2.36

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

121

1.87

2.36

1.0

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

245

0.44

2.34

1.3

1.7

725.00

25046.85

e6/l

—

137

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

345

0.53

2.33

3.1

1.7

—

(21494434) Karyotype in Bone marrow

745

0.68

2.32

1.0

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

390

1.46

2.31

1.2

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

390

1.46

2.31

1.2

1.3

—

(37208534) Antinuclear antibody arbitrary concentration in serum

143

0.35

2.30

1.3

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

693

0.67

2.28

1.4

1.3

—

nmol/l

—

(3000475) Leukocytes [#/volume] in Synovial fluid

172

1795

0.80

2.26

1.8

1.6

25414.89

14924.50

e6/l

0.93

133

1240

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

2.26

0.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.94

2.26

3.0

2.8

0.22

0.46

u/field

1.35

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

629

0.66

2.22

1.1

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

273

0.49

2.21

1.3

1.9

385.60

6205.65

e6/l

—

184

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

4842

41669

0.94

2.20

25.5

28.0

14.12

14.17

1.81

4744

41025

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

506

0.63

2.20

1.1

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

402

0.58

2.20

1.2

1.5

6.74

6.92

u/l

0.03

319

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

159

1052

1.27

2.20

1.9

2.2

31.57

28.00

mg/l

0.31

351

(3008536) Aspergillus sp Ab [Presence] in Serum

129

0.32

2.15

1.0

1.4

—

(3016038) Potassium [Moles/volume] in Urine

588

1.35

2.13

1.1

31.02

35.22

mmol/l

1.40

494

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

291

0.52

2.13

2.5

2.4

41.83

36.70

0.54

168

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

138

1464

0.78

2.11

1.3

25.06

39.75

u/l

2.67

108

1238

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

306

2997

0.85

2.11

2.3

2.5

24.42

22.73

au/ml

0.08

181

(3004809) Band form neutrophils/Leukocytes in Blood

135

1434

0.78

2.09

4.5

3.7

1.44

1.57

0.16

103

1247

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

197

1.62

2.06

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

138

0.36

2.02

1.7

1.3

53.67

296.68

nmol/24h

—

138

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

116

747

1.30

2.01

2.5

2.3

2.18

1.60

u/field

0.81

382

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

703

0.70

2.01

2.4

4.1

58.83

62.91

u/ml

0.05

682

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

225

1.56

2.00

1.2

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

553

1.35

1.97

1.1

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

699

5293

1.11

1.94

2.6

3.2

127.68

124.88

g/l

2.98

687

5139

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

248

0.50

1.93

1.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

239

2369

0.84

1.93

1.1

63.25

117.11

u/ml

3.03

757

(3006245) CD3-CD19+ cells/cells in Blood

144

0.41

1.92

2.1

1.8

8.00

11.08

—

127

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

146

0.40

1.92

2.0

1.8

29.29

30.08

—

133

(4015189) Microbial culture of sputum

214

0.47

1.92

1.4

2.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

1.91

0.0

1.1

—

(3022621) pH of Urine by Test strip

674

5103

1.11

1.88

3.6

3.3

6.18

6.05

3.13

517

3710

(3003329) Lymphocytes/Leukocytes in Synovial fluid

102

652

1.31

1.88

1.5

17.18

27.57

3.82

405

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

674

0.71

1.88

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

119

1.76

1.86

1.0

1.1

—

(3002582) Erythrocytes [#/volume] in Urine

3005

24141

1.06

1.86

3.9

3.8

139.10

115.98

e6/l

0.23

2558

18878

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

252

1786

1.18

1.85

2.0

2.2

89.41

96.81

ug/min

0.11

113

1003

(3037692) Legionella sp identified in Specimen by Organism specific culture

231

0.51

1.81

1.7

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

278

2703

0.86

1.80

1.3

45.71

58.21

au/ml

0.46

182

(3038177) Helicobacter pylori Ab [Presence] in Serum

596

0.70

1.75

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

183

0.46

1.74

1.2

1.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

1.73

0.0

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

565

0.69

1.72

1.1

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

0.00

1.72

0.0

1.1

—

0.35

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

131

1358

0.80

1.71

1.4

1.3

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

192

0.48

1.69

1.2

1.3

30.27

29.31

umol/l

0.10

178

(3011288) Drugs identified in Urine by Screen method Nominal

2.02

1.69

1.6

1.4

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

5928

50534

0.95

1.69

21.8

23.1

65.99

66.04

ml/min/173m2

0.08

5540

47658

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

346

1.40

1.69

4.5

2.7

227.83

217.38

u/l

0.43

340

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

225

0.52

1.68

1.1

—

(3002179) Metamyelocytes/Leukocytes in Blood

636

5837

0.90

1.67

3.3

3.8

0.59

0.68

0.34

161

1959

(3010838) Calcium [Moles/time] in 24 hour Urine

944

0.77

1.66

1.6

1.7

4.31

4.24

mmol/24h

0.07

782

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

123

0.41

1.66

1.2

—

(3002619) Bacteria identified in Specimen by Culture

179

0.47

1.65

1.3

—

(3044889) 12 lead EKG panel

4706

40335

0.95

1.64

5.0

5.2

0.63

0.93

0.23

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

235

2291

0.85

1.61

2.0

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

188

0.49

1.60

1.1

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

146

0.46

1.59

1.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6285

51624

1.05

1.58

5.1

6.1

6.22

6.16

mmol/l

2.39

5172

45430

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

273

0.58

1.58

1.0

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

273

0.58

1.58

1.0

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

2.02

1.57

1.4

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

152

1535

0.83

1.56

1.4

1.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

1.54

0.0

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

333

0.63

1.54

1.3

1.8

37.90

39.43

g/l

0.92

333

(3020876) Protein [Mass/time] in 24 hour Urine

101

1060

0.79

1.51

2.3

2.2

1.18

0.96

g/24h

0.28

606

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

300

0.61

1.50

1.0

280.87

294.84

mg/l

0.31

264

(40768446) Kidney Pathology biopsy report

140

0.48

1.48

1.0

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

408

0.68

1.45

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.55

1.45

1.9

1.8

18.41

15.73

umol/l

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

189

1.51

1.45

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

234

0.57

1.44

1.1

1.5

51.55

34.36

iu/l

0.94

196

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

131

0.45

1.43

1.0

1.1

—

1.83

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

648

0.75

1.41

1.1

1.4

—

(3044941) Cell count panel - Synovial fluid

123

1253

0.82

1.41

1.6

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

619

0.74

1.41

1.1

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

210

2039

0.86

1.40

1.3

1.4

242.40

254.91

ug/g

0.45

115

1291

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

653

1.26

1.39

1.2

1.4

269.29

319.02

titre

0.12

(3017732) Neutrophils [#/volume] in Blood

792

7129

0.92

1.39

2.7

3.1

5.89

5.23

e9/l

0.60

591

5780

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

207

2010

0.86

1.39

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

199

0.55

1.38

1.2

111.92

148.51

mmol/24h

1.66

199

(3016228) CD19 cells/cells in Blood

199

0.55

1.38

3.5

1.6

10.77

7.91

0.21

187

(3027945) Reticulocytes/Erythrocytes in Blood

1411

11181

1.06

1.38

2.3

1.74

1.78

0.63

1111

9818

(3027456) Digoxin [Moles/volume] in Serum or Plasma

376

2815

1.12

1.36

3.8

3.4

0.81

0.83

nmol/l

0.38

284

2272

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

179

1.50

1.34

1.1

44.50

324.80

ng/l

—

(3017181) Myelocytes/Leukocytes in Blood

686

6201

0.92

1.34

3.5

3.9

1.03

0.95

0.18

197

2102

(3014148) Varicella zoster virus Ab [Titer] in Serum

259

0.61

1.32

1.0

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

859

6702

1.08

1.32

1.6

2.0

0.19

g/l

0.02

738

6145

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

116

794

1.22

1.31

1.8

1.6

30.42

26.99

u/ml

0.33

155

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

4899

40103

1.04

1.31

28.6

30.4

329.74

329.68

g/l

0.18

4784

39727

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2891

23391

1.05

1.31

5.1

6.6

4.13

5.25

ug/l

1.40

2398

20537

(3018572) Chloride [Moles/volume] in Blood

210

1518

1.16

1.30

4.3

5.9

105.08

104.71

mmol/l

0.60

194

1359

(3039000) Anion gap in Blood by calculation

210

1518

1.16

1.30

4.3

5.9

11.55

11.35

mmol/l

0.39

194

1358

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

378

0.68

1.30

1.1

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

378

0.68

1.30

1.1

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

378

0.68

1.30

1.1

1.4

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.39

1.30

1.3

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

277

0.63

1.28

1.2

1.5

—

(21494814) CD8 cells/Lymphocytes in Specimen

192

0.57

1.24

3.6

1.6

27.31

31.57

0.50

192

(3018095) Leukocytes [#/volume] in Urine

3206

26032

1.04

1.23

4.6

4.5

202.99

145.77

e6/l

1.27

2554

19219

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

199

1917

0.87

1.23

2.2

2.4

1.80

1.93

mg/l

1.25

157

1649

(3005532) Lymphocytes/Leukocytes in Pleural fluid

451

0.72

1.22

1.3

1.5

53.21

69.71

1.53

369

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

333

0.68

1.21

1.1

—

(3021440) Promyelocytes/Leukocytes in Blood

658

5921

0.92

1.18

3.6

3.9

0.12

0.11

0.14

171

1833

(3014891) Appearance of Pleural fluid

199

0.59

1.18

1.8

1.5

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

1.17

0.0

15.3

—

186.41

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

0.00

1.17

0.0

1.3

—

0.12

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

1.17

0.0

3.8

—

0.00

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1123

9914

0.94

1.17

3.9

6.2

11.27

11.61

kpa

1.52

1071

9441

(40758358) Immune stain study

0.00

1.17

0.0

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

599

0.77

1.17

1.1

81.54

514.80

iu/ml

0.47

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

156

0.54

1.16

1.3

1.4

0.16

0.13

nmol/l

—

110

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

1.16

0.0

6.8

—

1.19

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1124

9917

0.94

1.15

3.9

6.2

4.94

5.06

kpa

4.16

1072

9443

(3044007) Cell count panel - Peritoneal fluid

228

0.62

1.14

1.4

1.8

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.44

1.14

1.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

634

1.23

1.13

1.2

1.4

67.78

62.61

titre

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

376

0.71

1.13

1.1

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

209

1989

0.88

1.11

1.2

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

709

5535

1.08

1.11

1.9

1.8

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

205

0.61

1.10

2.1

1.4

10.33

12.93

ug/l

0.23

182

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

224

1.38

1.08

1.6

1.8

54.55

61.29

ug/l

0.27

217

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

526

1.24

1.06

1.3

1.2

1.26

1.52

nmol/l

1.69

462

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

381

0.72

1.06

1.1

44.71

29.73

u/l

0.53

329

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

172

0.58

1.06

4.6

3.0

—

71.71

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

615

4785

1.08

1.06

3.0

3.8

1.97

2.14

mmol/l

0.50

431

3529

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

105

0.48

1.05

1.2

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

197

1.40

1.05

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

212

0.63

1.04

2.4

2.1

0.61

0.63

mmol/l

0.35

212

(3000093) Morphology [Interpretation] in Blood Narrative

846

0.82

1.03

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

491

0.77

1.00

1.1

1.2

95.69

99.79

pmol/l

0.24

491

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.99

0.0

1.4

—

307.20

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

105

1040

0.84

0.98

4.7

5.6

13.57

12.80

mg/l

0.73

945

(44790047) Parainfluenza type 1 nucleic acid detection

785

0.82

0.97

1.5

1.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

785

0.82

0.97

1.5

1.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

785

0.82

0.97

1.5

1.3

—

(44806118) Parainfluenza type 4 nucleic acid detection

785

0.82

0.97

1.5

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

294

1.31

0.97

1.4

1.3

0.96

1.16

nmol/l

0.99

209

(3045414) Leukocytes [Presence] in Urine

741

6582

0.94

0.97

2.3

2.2

0.00

0.01

estimate

1.06

157

1136

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.96

0.0

9.8

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

213

1583

1.13

0.95

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

363

0.74

0.95

1.3

813.30

184.88

ug/l

0.40

190

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

259

1.32

0.94

4.7

6.3

67.35

74.69

0.89

199

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3289

26853

1.04

0.93

2.8

3.3

146.63

159.51

ug/l

1.94

2771

24166

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

211

1978

0.89

0.93

1.5

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

624

0.80

0.93

1.1

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

624

0.80

0.93

1.1

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

624

0.80

0.93

1.1

1.4

—

(3042631) Mycobacterium sp identified in Specimen

132

1276

0.86

0.92

2.4

2.7

—

(3032773) Endomysium IgG Ab [Titer] in Serum

416

1.25

0.92

1.0

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

214

1601

1.12

0.88

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

656

0.81

0.88

1.1

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

242

0.69

0.87

1.1

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

139

1331

0.87

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

214

1603

1.12

0.86

1.2

—

(3026782) Osmolality of Urine

1886

15258

1.04

0.86

3.4

3.2

528.76

521.11

mosm/kgh2o

0.95

1704

13357

(3000034) Microalbumin [Mass/volume] in Urine

617

0.81

0.85

2.6

3.1

38.88

32.35

mg/l

0.19

458

(3000764) Benzodiazepines [Presence] in Urine

1.53

0.85

1.4

1.1

—

(3027944) Amphetamines [Presence] in Urine

1.51

0.81

1.4

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

107

769

1.17

0.81

2.6

3.0

—

(44813793) Dust mix specific IgE antibody measurement

257

0.72

0.81

1.0

1.1

—

(3047181) Lactate [Moles/volume] in Blood

288

2203

1.10

0.80

3.9

5.3

1.39

1.37

mmol/l

0.14

260

1960

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.74

0.80

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.55

0.79

1.4

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

253

2322

0.91

0.79

2.6

3.1

—

0.95

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

396

0.78

0.76

1.4

1.5

2.66

2.45

0.08

325

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

2.20

0.76

1.0

1.1

—

5.97

—

(3027008) Opiates [Presence] in Urine

1.48

0.75

1.4

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

124

1.42

0.75

1.4

1.5

—

(3019977) pH of Arterial blood

1138

9901

0.96

0.75

3.9

6.2

7.42

0.44

782

5491

(4198724) Urine methamphetamine measurement

2.09

0.74

1.4

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.54

0.73

1.0

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.54

0.73

1.0

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

583

5157

0.94

0.72

2.6

3.0

57.76

54.67

ml/min/173m2

1.37

257

2488

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

0.54

0.72

10.3

8.3

13.50

13.89

—

(3028300) Cannabinoids [Presence] in Urine

1.47

0.72

1.4

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

1.60

0.72

1.1

—

(3025159) Blasts/Leukocytes in Blood

664

5849

0.95

0.72

3.6

4.0

0.13

0.32

1.24

156

1690

(4024509) Urine culture

374

3356

0.93

0.71

2.2

2.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

147

1.37

0.71

1.2

1.1

0.99

1.24

u/l

—

(1761868) Lipid panel - Serum or Plasma

1656

13421

1.04

0.71

3.7

4.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

155

1.35

0.69

1.1

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

162

0.67

0.69

1.0

1.1

—

21.20

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

509

0.82

0.69

3.1

3.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2297

18736

1.03

0.69

4.9

5.4

21.39

22.79

4.90

1237

10672

(3020650) Glucose [Presence] in Urine

170

1.33

0.68

3.3

1.7

0.00

0.04

estimate

0.80

170

(3016244) Insulin [Units/volume] in Serum or Plasma

0.60

0.68

1.4

2.4

26.27

15.52

mu/l

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

181

0.69

0.68

1.3

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

181

0.69

0.68

1.3

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

181

0.69

0.68

1.3

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

181

0.69

0.68

1.3

1.1

—

(3016750) Collection duration of Urine

435

0.81

0.68

2.0

1.9

501.29

504.14

min

0.05

298

(3034274) Bile acid [Moles/volume] in Serum --fasting

229

1.28

0.68

1.2

6.87

10.61

umol/l

0.95

155

(3028433) Virus identified in Specimen by Culture

171

0.68

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.52

0.67

1.4

1.3

—

(3016502) Oxygen saturation in Arterial blood

1092

8791

1.04

0.66

3.8

6.3

95.08

94.93

0.34

1050

8456

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

186

1.30

0.65

2.8

2.6

7.61

7.47

mmol/l

0.11

121

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

514

0.83

0.65

1.7

108.75

116.36

ng/l

0.32

514

(40762887) Creatinine [Moles/volume] in Blood

1.54

0.64

1.4

1.7

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

108

0.62

0.64

2.1

1.5

8.91

9.86

ug/l

—

108

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.58

0.64

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

207

0.73

0.64

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.61

0.63

1.3

1.5

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

0.58

0.62

4.7

1.4

53.33

48.07

pmol/l

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.58

0.62

1.3

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.61

0.0

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.61

0.0

1.1

—

(3016879) Cocaine [Presence] in Urine

1.42

0.61

1.4

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.59

0.0

2.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

242

1.24

0.59

1.1

—

(4133840) Spirometry

0.62

0.58

1.6

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.57

0.54

1.0

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.57

0.54

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

200

0.75

0.53

1.1

—

(3049717) Cytology report of Urine Cyto stain

416

3670

0.95

0.52

2.9

3.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

119

1.34

0.52

1.2

1.0

1728.05

1564.10

miu/ml

0.21

119

(3020874) Milk IgE Ab [Units/volume] in Serum

0.60

0.52

1.0

1.1

—

1.29

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.41

0.52

1.2

2.0

1.48

1.07

ug/l

0.25

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.41

0.52

4.1

5.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

112

0.67

0.52

1.1

1.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.52

0.52

1.0

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

130

986

1.10

0.50

1.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4261

35195

1.02

0.49

4.0

6.3

12.32

12.98

umol/l

1.98

3863

33501

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.61

0.46

1.0

2.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.68

0.46

1.0

1.6

12.25

16.82

mm/h

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

100

0.67

0.46

8.5

8.8

8.95

5.79

kpa

—

100

(3017704) Immunofixation for Urine

503

0.86

0.46

1.3

1.4

—

(3003396) Base excess in Arterial blood by calculation

1150

9875

0.97

0.43

3.8

6.1

1.43

0.98

mmol/l

3.55

872

8018

(3034891) Synovial lining cells/cells in Synovial fluid

322

1.17

0.43

1.3

1.5

2.91

3.35

0.13

(3004716) Salmonella sp identified in Stool by Organism specific culture

228

1789

1.07

0.42

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

210

0.80

0.42

1.4

11.27

15.30

g/l

1.18

162

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.41

0.0

8.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.41

0.0

1.2

—

4.00

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.41

0.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.41

0.0

1.2

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.41

0.0

1.2

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.41

0.0

1.1

—

2147.86

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

6.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.40

0.0

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

206

1836

0.94

0.40

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

137

1239

0.92

0.39

1.6

1.7

3.10

18.08

iu/l

0.52

411

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

0.39

0.0

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

978

7963

1.03

0.38

1.7

1.9

—

(3022689) Creatine [Moles/volume] in Urine

170

0.79

0.37

1.1

1.4

6.73

6.40

mmol/l

0.10

170

(3036071) Salmonella sp Ab [Titer] in Serum

0.70

0.37

1.1

—

(4211845) Urine protein measurement

359

0.86

0.36

5.1

4.3

—

(3006462) Nitrate [Presence] in Urine

332

0.86

0.36

5.3

4.4

—

(44806420) Estimation of glomerular filtration rate

385

0.87

0.36

2.8

2.7

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

0.62

0.35

1.0

—

0.83

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

128

1153

0.93

0.35

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

866

0.92

0.34

1.1

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

250

2201

0.95

0.34

1.6

1.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.35

0.34

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

301

2401

1.05

0.34

5.3

4.7

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

969

7905

1.03

0.34

4.1

6.8

119.85

117.98

g/l

2.26

953

7720

(3022313) Gas panel - Capillary blood

427

3709

0.96

0.34

3.2

4.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

267

0.85

0.34

1.0

1.1

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

159

1.21

0.33

1.4

1.3

18.79

32.19

1.20

106

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

378

1.13

0.33

5.5

3.1

1.24

1.20

0.04

378

(3027035) Albumin [Mass/time] in 24 hour Urine

0.70

0.33

1.7

1.2

—

1066.34

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

863

0.92

0.33

1.1

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

476

1.11

0.31

1.2

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

282

0.86

0.31

1.1

1.2

—

(4146454) Self-monitoring of blood glucose

842

0.92

0.30

2.5

2.7

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.27

0.30

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.27

0.30

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.27

0.30

1.0

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

146

0.80

0.30

1.1

1.2

36.25

296.23

u/l

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1078

8828

1.02

0.30

2.7

3.6

5.86

5.82

kpa

0.72

1047

8582

(3022493) Free Hemoglobin [Mass/volume] in Plasma

334

0.88

0.29

1.0

1.6

55.47

65.65

mg/l

0.63

220

(3043410) Blood group antigens tested for on Red Blood Cells

236

0.85

0.29

1.5

2.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

494

1.10

0.29

1.2

1.4

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

608

5228

0.97

0.29

4.0

7.7

0.75

0.63

12.52

602

5188

(37021550) Renin [Units/volume] in Plasma --upright

118

0.78

0.29

1.4

1.3

29.07

83.76

mu/l

—

(3009343) pH of Capillary blood

662

5390

1.03

0.28

3.0

4.0

7.42

0.11

556

4538

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.33

0.28

1.0

1.2

—

(3020491) Glucose [Moles/volume] in Blood

456

0.90

0.28

1.8

2.5

7.45

7.21

mmol/l

0.29

312

(3051101) Glucose [Moles/volume] in Cord blood

163

0.82

0.28

3.9

6.0

10.24

8.43

mmol/l

1.54

163

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

279

0.87

0.28

1.1

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

1.26

0.27

1.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

679

5536

1.03

0.27

3.1

4.0

5.18

5.17

kpa

0.17

599

5237

(3021901) Oxygen saturation in Capillary blood

250

2003

1.04

0.27

2.7

3.1

87.74

88.50

0.94

241

1951

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

212

1856

0.95

0.26

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

212

1856

0.95

0.26

1.4

—

(3004775) Volume in Urine collected for unspecified duration

636

0.92

0.26

1.9

2.1

579.15

653.65

0.69

393

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

306

1.12

0.26

1.0

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

143

0.82

0.25

1.6

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

859

0.93

0.25

1.1

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.28

0.25

1.2

1.1

—

3333.33

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

285

0.88

0.25

1.1

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

486

0.91

0.25

1.8

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

101

901

0.94

0.25

1.1

1.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

115

0.80

0.24

3.1

2.3

0.77

0.67

ug/l

0.39

115

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.24

0.24

1.4

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.35

0.23

1.0

1.1

6.52

6.26

mmol/l

—

(3013512) EKG study

2906

24519

0.99

0.23

4.5

4.6

0.83

0.69

0.58

(3002523) Influenza virus A Ag [Presence] in Specimen

265

0.88

0.22

1.0

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.27

0.22

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

0.76

0.22

4.4

7.8

10.57

10.21

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

194

0.86

0.22

1.0

1.2

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

0.19

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.21

0.0

6.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

8.63

—

(44806071) Cardiolipin IgM antibody measurement

1.19

0.21

1.2

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.19

0.21

1.0

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

3.16

—

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

0.00

0.21

0.0

9.3

—

55.60

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

5.0

—

360.10

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.21

0.0

1.1

—

1.00

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(36660577) Edoxaban [Mass/volume] in Platelet poor plasma by Chromogenic method

0.00

0.21

0.0

1.7

—

139.80

—

(3035933) Granulocytes/Leukocytes in Blood

159

1270

1.05

0.21

2.6

3.2

61.59

59.78

0.82

159

1270

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

216

1.12

0.20

1.2

15.39

14.97

pmol/l

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.01

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.20

0.0

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

130

0.84

0.20

1.0

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

101

892

0.95

0.20

1.2

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

1033

8768

0.98

0.19

2.4

65.09

66.79

e9/l

0.88

807

6472

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

161

1.14

0.19

1.5

1.6

0.49

0.39

ug/l

0.32

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

359

2923

1.03

0.19

2.8

3.2

4.25

4.26

pmol/l

0.06

298

2523

(3036525) Urea [Moles/time] in 24 hour Urine

1.14

0.19

2.5

3.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

109

958

0.95

0.18

1.1

—

20.08

—

(3023383) Lactate [Moles/volume] in Pleural fluid

356

0.92

0.18

1.3

4.00

3.28

mmol/l

0.47

326

(3002032) Base excess in Venous blood by calculation

1014

8598

0.98

0.18

2.8

3.6

2.14

1.78

mmol/l

2.69

879

7364

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.13

0.17

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

559

1.06

0.17

1.2

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

104

912

0.95

0.17

1.2

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

164

1.12

0.16

1.1

—

(3004451) EKG impression Narrative

561

1.06

0.16

1.2

1.3

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

0.77

0.15

1.3

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

344

0.92

0.15

2.0

1.8

88.45

105.00

umol/l

1.84

344

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.75

0.15

1.7

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

326

0.92

0.15

1.2

1.4

—

(3045424) Erythrocytes [Presence] in Urine

391

3202

1.02

0.15

2.0

2.1

0.00

0.33

estimate

0.54

135

799

(3015235) Bicarbonate [Moles/volume] in Capillary blood

356

3041

0.98

0.14

2.8

3.2

24.94

24.96

mmol/l

0.03

347

2991

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

126

1.13

0.13

1.1

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

159

0.89

0.12

1.1

1.2

1.19

2.18

mmol/l

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

835

0.96

0.12

1.5

78.61

63.07

5.71

520

(3044927) Protein electrophoresis panel - Urine

113

979

0.96

0.12

1.2

—

(44786800) Granulocytes/Leukocytes in Body fluid

151

1.11

0.12

1.4

1.3

24.36

20.66

0.16

114

(3024869) Neuronal Ab [Presence] in Serum

127

1.12

0.12

1.0

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

150

1291

0.97

0.12

1.2

—

(3037121) Protein [Mass/volume] in Urine

309

2633

0.98

0.11

2.4

2.8

1947.79

680.84

mg/l

0.37

1119

(3037756) Immunofixation for Serum or Plasma

252

2064

1.02

0.11

1.3

1.5

—

(3012565) Volume of 24 hour Urine

307

1.06

0.10

1.7

2.3

1582.31

1793.83

0.56

258

(3010144) Erythrocytes [#/volume] in Synovial fluid

686

1.04

0.10

1.4

241868.70

185145.97

e6/l

0.19

463

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.88

0.09

1.1

1.6

46.70

49.85

umol/l

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

146

1.09

0.08

1.2

1.3

1.16

1.18

mmol/l

0.64

146

(3005011) Chlamydia sp Ab [Titer] in Serum

0.80

0.08

2.0

1.8

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.80

0.08

2.8

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

122

1.10

0.08

1.1

1.0

—

(3024263) Appearance of Synovial fluid

368

1.05

0.08

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

139

1188

0.98

0.08

1.3

1.4

0.33

0.27

mg/l

0.48

406

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.08

0.07

1.0

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

137

0.92

0.07

1.0

1.1

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

137

0.92

0.07

1.3

80.19

73.14

—

116

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

154

0.92

0.07

1.0

1.2

105.00

132.03

nmol/l

0.39

111

(3016330) Potassium [Moles/time] in 24 hour Urine

1.03

0.07

1.6

1.2

—

(3012544) pH of Venous blood

1057

8890

0.99

0.07

2.8

3.6

7.38

1.71

642

5373

(4212803) Bone marrow aspirate examination

0.85

0.06

1.1

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

161

0.93

0.06

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

119

979

1.02

0.04

1.3

1.4

0.91

0.82

nmol/l

0.44

792

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

278

0.96

0.04

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

278

0.96

0.04

6.2

6.3

32.43

212.50

ug/l

0.93

176

(3025577) Chromium [Mass/volume] in Blood

480

0.98

0.04

1.9

2.1

1.68

2.26

ug/l

0.95

402

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

109

1.07

0.04

1.0

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

832

0.98

0.03

5.9

3.8

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

243

0.96

0.03

1.1

1.4

18.00

22.01

0.31

203

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

160

1324

1.01

0.03

1.3

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6054

50651

1.00

0.03

7.2

7.9

42.11

41.01

mmol/mol

12.53

5102

45779

(3028626) Oxygen [Partial pressure] in Capillary blood

269

2264

0.99

0.03

2.6

3.1

7.52

7.73

kpa

1.49

260

2209

(3045683) HLA typing for celiac disease panel - Blood or Tissue

141

0.95

0.03

1.1

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

208

0.96

0.02

1.0

1.2

1.39

1.37

mmol/l

0.04

127

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.07

0.02

1.4

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

113

1.04

0.00

1.0

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

130

0.96

0.00

1.3

1.1

257.88

292.56

pmol/l

—

(40762814) Titanium [Mass/volume] in Blood

139

1.02

0.00

2.2

2.1

2.82

3.28

ug/l

—

(3026389) Candida sp identified in Specimen by Organism specific culture

100

834

1.00

0.00

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

364

0.99

0.00

4.8

5.3

91.90

120.31

u/ml

—

113

(3036670) Protein [Mass/volume] in Synovial fluid

251

1.00

0.00

1.1

1.2

41.03

39.28

g/l

0.39

110

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

118

0.99

0.00

1.0

1.1

—

(3017569) Oxygen content in Arterial blood

550

1.00

0.00

2.1

2.0

15.54

15.48

0.05

550

(3028679) Herpes simplex virus Ab [Presence] in Serum

147

1.02

0.00

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

222

1856

1.00

0.00

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

334

2793

1.00

0.00

3.5

4.4

24.98

24.83

mmol/l

0.36

266

2496

(3016135) IgD [Mass/volume] in Serum

0.00

-0.00

0.0

1.1

—

59.95

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

-0.00

0.0

2.2

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.0

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.5

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.01

-0.00

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

-0.00

0.0

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.4

—

0.19

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

16.40

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.00

-0.00

7.3

4.8

42.83

54.67

ug/min

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

233.38

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.91

-0.00

1.0

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.84

-0.00

1.0

1.2

10.80

10.18

u/l

—

(3042517) Benzodiazepines panel - Urine

0.00

-0.00

0.0

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

-0.00

0.0

1.0

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

10.37

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

-0.00

0.0

2.4

—

13.64

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

-0.00

0.0

1.0

—

4.46

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

2.7

—

3.07

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

1.68

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.85

-0.00

1.0

1.1

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

2950.00

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

5.6

—

14.00

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_ALZHDEMENT and mortality.

Females

Parameter	HR [95% CI]	p-value
F5_ALZHDEMENT	2.398 [2.17, 2.65]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.03

During the follow-up period (1.1.1998 — 31.12.2019), 48483 out of 70483 females with F5_ALZHDEMENT died.

Males

Parameter	HR [95% CI]	p-value
F5_ALZHDEMENT	2.838 [2.47, 3.27]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.006

During the follow-up period (1.1.1998 — 31.12.2019), 27543 out of 38138 males with F5_ALZHDEMENT died.

Mortality risk

Mortality risk for people of age

years, who have F5_ALZHDEMENT.

N-year risk	Females	Males
1	0.185%	0.525%
5	1.168%	2.954%
10	3.006%	7.145%
15	5.373%	13.483%
20	9.032%	22.437%

Relationships between endpoints

↥

Index endpoint: F5_ALZHDEMENT – Dementia in Alzheimer disease

GWS hits: 20

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Dementia in Alzheimer disease

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints